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Summary
Leishmama mexiccma mexiccma is a protozoan parasite that causes local and 
diffuse cutaneous leishmaniasis. There are no effective current vaccines, and current drugs 
have serious side effects. There is a wealth of evidence, both in viiro and in vivo^ to 
suggest that the protective murine Immune response involves the production of a set of 
partially oxidised products of nitrogen called Reactive Nitrogen Intermediates (RNI), RNI 
are synthesised during a protective murine immune response by the enzyme inducible 
Nitric Oxide Synthase (iNOS) and are extremely diverse both in their possible chemical 
targets and in their biological effects. Inhibition of RNI production in murine cutaneous 
leishmaniasis allows the parasite to survive in normally resistant hosts, and it is believed 
that they are the final effector mechanism in the protective Tifi-type immune response.
Very little was known about the targets of RNI in Leishmania. This thesis aims to 
investigate the processes by which RNI kill L. m. mexicona. This species was chosen 
because it has recently become possible to grow it as amastigotes axenically in viiro. [^H]- 
thymidine uptake and transformation efficiency viability assays were optimised for use 
with these axenic amastigotes. In addition, because of the unusual culture conditions for 
amastigotes - Schneider’s Drosophila Medium, pH 5.5, with 20% (v/v) foetal calf serum - 
it was necessary to develop suitable methods for RNI production and detection.
Production of RNI by S-nitroso-N-acetyl penicillamine and by acidified nitrite was used.
Little work has been done on the role of RNI in the immune response to L  m. 
mexiccma. Therefore, the susceptibility of this species to RNI produced by murine 
macrophages was determined. The kinetics of toxicity in axenic culture showed that RNI 
were cytotoxic rather than cytostatic to this species, and that RNI can take up to several 
hours to kill the parasite. RNI did not affect, and were not affected by various other
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components of the macrophage defence mechanism, namely p-glucuronidase, cathepsîn D 
and hydrogen peroxide,
L. m. mexicana amastigotes were shown not to be particularly resistant to RNI 
compared to promastigotes, Escherichia coli, and the murine macrophage cell line J774. 
Low levels of RNI were also shown to be insufficient to induce a resistant phenotype in 
the parasite.
There have been many suggestions of the possible antileishmanial targets of RNI, 
based on the action of RNI in other cell types. These include inhibition of the 
mitochondrial electron transport chain and other iron-containing proteins, damage to 
lipids, damage to DNA, damage of membrane components held on to the membrane by 
glycosyl-phosphatidylinositol (GPI) anchors, and inhibition of proteins that contain 
sulphydryl groups or tyrosine residues. The effect of RNI on the GPI-anchored 
glycoinositolphospholipids (GIPLs), DNA and mitochondrion of L  m. mexicana was 
examined. Of these, only the mitochondrion was affected by RNI at concentrations which 
approximated to the toxic concentrations, though DNA and GIPLs could be damaged by 
much higher concentrations of RNI. Inhibition of the mitochondrion was sufficient to 
account for all the toxicity of RNI to the parasite, since uncoupling the mitochondrial 
membrane with 2,4-dinitrophenol (DNP) caused similar kinetics of toxicity to RNI. It was 
also possible to inhibit the DNase activity of serum, and the implications of this to other 
biological systems are discussed.
The involvement of the mitochondrion in the toxicity of RNI to amastigotes is not 
surprising given the evolutionary conservation of the enzymes in the mitochondrial 
electron transport chain, and given the involvement of these enzymes in RNI toxicity to E. 
coli and mammalian cells. However, since L  m. mexicana normally reside in low oxygen
111
tensions, one might have expected that they would not be so reliant on their 
mitochondrion.
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1. Introduction
1.1 Leishmaniasis
1.1.1 Prevalence
Leishmaniasis is a set of diseases caused by protozoan parasites of the genus 
Leislimanici. The number of infected people in the world at present is estimated to be 12 
million, and 350 million live in areas where the disease may be caught (1). In all, 
leishmaniasis was responsible for approximately 75 thousand deaths in 1991 (1). The 
disease is present on all continents except Australia, and can be found in a band across the 
globe that extends from Texas, the South of France and China down to Argentina, South 
Africa, and Thailand (1,2). It is found both in rural and urban populations (1).
The parasite is carried by sandflies of the genera Lulzomyia or Phlebotomus (2-4), 
and is maintained in urban areas by reservoirs mainly in dogs and humans, and in rural 
areas by reservoirs in rodents (1,5).
1.1.2 Pathology
Leishmaniasis may be grouped into four main types of disease: local cutaneous, 
diffuse cutaneous, muco-cutaneous, and visceral (1,6).
Local cutaneous leishmaniasis is rarely fatal, but is often disfiguring (1,5). A 
lesion develops at the site of the sandfly bite, and is usually self-healing after several 
months (6), though it may ulcerate, leaving the site of the lesion open to secondary 
infections.
Diffuse Cutaneous Leishmaniasis (2,7,8) is a condition in which the initial lesion 
can spread over much of the body. The disseminated lesions do not ulcerate, but are full 
of parasites, mainly in highly vacuolated macrophages. The condition progresses slowly 
and becomes chronic.
Muco-cutaneous leishmaniasis is almost never self-healing (6). It occurs as a 
result of the parasite spreading from an initial lesion at the sandfly bite to the mucosal 
membranes. The lesions that develop can restrict airways and be grossly disfiguring, often 
requiring plastic surgery to repair (6).
Visceral leishmaniasis is rarely self-healing, and is usually fatal if untreated (1,6). 
The parasites spread throughout the body, most notably to the liver, spleen, and bone 
marrow, causing hepato- and spleno-megaly followed by multiple organ failure.
Patients with immune disorders, for example Acquired Immunodeficiency 
Syndrome (AIDS), often present with unusual symptoms of leishmaniasis (9), including 
infection of the digestive tract (10), parasite filled Kaposi’s sarcoma (11), and polyarthritis 
( 12).
1.1.3 Species classification
Leishmaniasis is caused by single celled eukaryotic parasites of the genus 
Leishmaiiia, class Zoomastigophora, order Kinetoplastida, suborder Trypanosomatina (5). 
Species of the parasite are grouped primarily according to their geographical distribution, 
and the types of disease that they are likely to cause.
In the Old World (Eurasia and Africa), visceral leishmaniasis is caused by two 
species of parasite, L. clonovam and L. infanliini, and cutaneous leishmaniasis by L. 
tropica, L. major, and L. aethiopica.
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In the New World, American visceral leishmaniasis is caused by L. chagasi, 
mucocutaneous leishmaniasis by members of the L. brasiliensis complex, and cutaneous 
leishmaniasis by members of theL. brasiliensis and the 1 . mexicana complexes (2). L. 
brasiliensis and L. mexicana are divided into subspecies described in Table 1.1 (2).
Table 1.1: Species classification of the American Leishmania.
Leishmania braziliensis complex Leishmania mexicana complex
L. braziliensis braziliensis L. mexicana mexicana
L. b. guyanensis L. m. amazonensis
L. b. panamensis L. m. garnhami
L. peruviana L. m. veneziielensis
L. m. pifanoi
The disease caused by each species of parasite has been oversimplified in the 
description outlined above. Many of the parasites can cause less severe, or more severe 
diseases depending on the host immune status (2,5,6,8).
The species with which this thesis is mainly concerned isL. w. mexicana. 
Normally, this species causes ulcerating simple cutaneous lesions, though occasionally it 
can cause diffuse cutaneous leishmaniasis in hosts with an unusual immune response (2,8)
1.1.4 Treatment
First-line treatments are still based on the pentavalent antimonial drugs such as 
sodium antimony gluconate (Pentostam) and antimony-N-methyl-glutamine (Glucantime)
(1,6), developed over 40 years ago. Second-line drugs are amphotericin B or pentamidine, 
but these are toxic, and require prolonged treatment. The side effects of the drugs are such 
that they are only used when the disease is unlikely to regress spontaneously, or is likely to 
cause permanent scarring (6). Some cutaneous lesions, and diffuse cutaneous lesions are 
only slightly affected by treatment (7), so the indicated treatment for these leishmaniases is 
to do nothing, while for the other forms, treatment is indicated.
Immunotherapy, in which a parasite preparation is injected along with an 
appropriate immunomodulator to induce a protective immune response has sometimes 
been found to be as effective a treatment as the conventional treatments (13,14).
There is currently no safe, effective vaccine available. Several vaccine 
formulations are at present being developed (2,14), ranging from peptide vaccines to killed 
Leishmania in conjunction with BCG. The effectiveness of the risky practice of deliberate 
infection with a strain that causes cutaneous leishmaniasis in an area of the body that is not 
normally visible, indicates that a suitable vaccine is a realistic prospect (2,14,15).
However, none of the present formulations are currently effective enough to be prescribed 
routinely.
1.2 Leishmania life cycle.
All members of the genus have a digenetic life cycle, being transmitted between a 
variety of mammalian hosts by sandflies of the genera Luizomyia or Phlebotomus (2-4).
The generally accepted life cycle of Leishmania (5,16,17) is one in which the 
parasite lives in the mammalian host as an amastigote in a parasitophorous vacuole (PV) 
of the mammalian macrophage. In the PV, the amastigote divides, until the macrophage 
bursts, releasing amastigotes to infect other macrophages. When the sandfly takes a blood
meal from near the lesion, it collects Leishmcinia-mfQcic6. macrophages. In the gut of the 
sandfly, the amastigotes transform to promastigotes, where they attach to the gut wall of 
the sandfly, and mature from procyclic promastigotes to metacyclic promastigotes as they 
migrate to the sandfly mouthparts. The cycle is completed when the infective metacyclic 
promastigotes are injected into the mammal, where they infect macrophages and transform 
to amastigotes again.
The evidence that amastigotes were obligate intralysosomal parasites was based on 
the findings that it was impossible to grow amastigotes extracellularly at the temperature 
of the mammalian host (18), that it was unusual to imà Leishmania in cells other than 
mononuclear phagocytes, and nonphagocytic cells do not support the growth of 
amastigotes (19).
Recently, however, this simple view has been challenged. L. major can not only 
reside in macrophages, but also in dendritic cells (20,21), which may protect the parasite 
from immune attack, and/or may serve to continually provide the immune system with 
material for maintenance of immunological memory (22). On top of this, during L. major 
infection of C57BL/6 mice, only 30-40 % of the parasites were found in cells with typical 
markers for macrophages (F4/80% BM-8  ^and/or MOMA-2^) or dendritic cells (NLDC- 
145^) (22). This meant that 60-70 % of the amastigotes were actually in an unidentified 
cell type.
It has now also become possible to grow amastigotes from some species of 
Leishmania at the temperature of the mammalian host for several sub-passages. Methods 
have been described for L. m. mexicana, L. m. pifanoi, L. b. panamensis, L. b, braziliensis, 
L. donovani (reviewed by Bates, 23).
The work presented in this thesis focuses on L, m. mexicana since this species was 
the one in which the culture conditions for amastigotes were most similar to those of the 
PV, in that they were at pH 5.5 and not pH 7.2. Axenically cultured L. m. mexicana 
amastigotes are very similar to amastigotes isolated directly from a lesion (24,25). They 
are the same size and shape (3*-5 pm on the major axis), and have the same ultrastructure 
as lesion amastigotes. They have megasomes, which are lysosome-like sti uctures which 
are not present in promastigotes, and they have a short, non-emergent flagellum in a 
flagellar pocket. Their cysteine protease pattern is similar to lesion amastigotes and they 
are almost as infective as lesion amastigotes.
An important factor in murine resistance to leishmaniasis is the production of 
Reactive Nitrogen Intermediates (RM). In order to understand the role that RM  play, it is 
first necessary to explain what RM  are, and the mechanism of their production.
1,3 The composition of RNI.
RNI are a gr oup of partially oxidised products of nitrogen. They are extremely 
diverse, and the dififerent RM  all have different reactivities. It is not known which of the 
RM  are the most physiologically significant in any of the biological systems that have 
been studied. The reactions by which they are created are summarised in Table 1.2 .
Table 1.2; The reactions by which RNI are formed.
RM  molecule | Creation Reaction
-------------------------------------  — I-------------------------------------- — — - , ------------------------------------------' '
NO I Arginine + Citmlline -i- NO (26)I
(Nitric oxide) 1 RS-NO ^  RS + NO (27,28)
1
I [Fe(CN);NO]^- + H ,0 + hv -> [Fe(CN)5H,0]'- + NO (28)
NO+ HGNG + H" -> NG+ + H^G (28)
NO NG + e‘ NG (Reduction by cytochrome a,) 
HNG -> HN NG (28)
HONG 
(Nitrous acid)
NG; + H" HGNG (28)
NG" + H^G HGNG + H" (28)
L.
HGNG + H" “> H^NG/ (28)
HNO
r
RSNG + R SH ^  R-R + HNG (29)
GONG
(Peroxynitrite)
r
G ; + N G -^ GGNG (30)
NG" + H2O2 "> GGNG + 2 H" (30)
u
RSNG
(S-nitrosothiol)
r
NO* + RSH RSNG + H* (28)
RSH + NO in oxygenated solution RSNO (Mechanism unknown) 
(31)
R SNO + RSH ^  R SH + RSNO (27-29)
Transition metal - 
NG complexes
r
Chelation of NG by transition metals.
1
NGy
(Nitrite)
r
2 NG + G2 -> 2 NG2 THEN 2 NG2 -> N2G4 
THEN N2G4 -I- H2G ^  NO2 4- NG; (32)
NG + NGg -> N2G3 THEN N2O3 + U^O -> 2 NG; (32)
NG,
(Nitrate)
t~
2  NO + O2 ^  2  NO; THEN 2 NO; -> N;0;
THEN NjOj + HjO -> NO;' + NO; (32)
NO + Oxy-haemoglobin-> NO," + Met-Haemoglobin (33)
1.4 Production of RNI in biological systems
RNI are produced mainly by a group of enzymes called the nitric oxide synthases 
(NOS). NOS catalyses the reaction t-Arginine + 0 2 "^ Citrulline + NO (26,32). NO is 
very short lived in biological media, with a half life of 0.1 s (34), and quickly reacts with 
oxygen, iron and amine groups to form many of the other RNI via the creation reactions 
described in Table 1.2.
There are three isoforms of NOS in mammals, endothelial (eNOS), neuronal 
(nNOS) and inducible (INOS) (35). eNOS and nNOS are often grouped together as cNOS 
(constitutive NOS). This is because the regulation of their activity differs from iNOS in 
that post-translational regulation is important. They are affected by calcium levels and by 
phosphorylation. Their is well below that of iNOS (36), and they are primarily 
involved in the regulation of vascular tone and neural organisation and communication.
iNOS, on the other hand is regulated primarily pretranslationally at the level of 
transcription (35-38), and the stability of its mRNA can be affected by TGFp (36). Like 
the other two isoforms, it requires NADPH and tetrahydrobiopterin (BH4) as cofactors (35) 
and is a member of the cytochrome P450 class of enzymes to which cytochrome a„ the last 
enzyme in the mitochondrial electron transport chain belongs. It binds calmodulin too 
tightly to be responsive to physiological changes in calcium levels (39), although calcium 
may be involved in its induction, since the calcium ionophore A23187 can synergise with 
lipopolysaccharide (LPS) to induce iNOS in murine macrophages (40,41). iNOS can be 
found in hepatocytes, macrophages, chondrocytes, adenocarcinoma cells, kératinocytes, 
and respiratory endothelia (36). iNOS is the enzyme that produces the RNI involved in the 
murine immune response against Lm/r/wrt/r/a.
1.5 Inhibition of RNI production
RNI levels may be reduced in biological systems by preventing the production of 
NO by iNOS, or by mopping up the RNI produced.
1.5.1 Prevention of RNI production
RNI production by iNOS is usually experimentally inhibited by the addition to the 
solution of arginine analogues, eg N-monomethyl-L-arginine (i.-NMMA) (43-53), N- 
iminoethyl-L-ornithine (l-NIO) (54), or N-amino-L-arginine (55). These inhibitors 
compete with e-arginine for the active site of iNOS (42), so their effects may be reversed 
by the addition of more e-arginine.
It is often mistakenly assumed, however, that these molecules are specific for the 
nitric oxide synthases. They are all taken up by cells via the amino acid transport systems 
y" and y"L (51,56). These systems are also responsible for the uptake of many other 
amino acids (eg ornithine, lysine, arginine and citrulline), and the addition of the arginine 
analogues can cause efflux of these other molecules (51). The half saturation 
concentration (K,) of l-NMMA for the transport systems (151 pM for y" and 7.5 pM for 
y"L) (51) is well below the concentration at which it inhibits RNI production in intact cells 
(100-500 pM) (43-53). Therefore, while any biological effect i-NMMA may correlate 
with inhibition of RNI production, the analogue also disrupts the amino acid balance in 
cells.
The Ki of arginine for system y" is 55.7 pM and for y"L, it is 2.4 pM (51). In most 
in vitro media, the concentration of arginine is very high (in DMEM it is 400 pM, in 
RPMI it is 2 niM), compared to the concentration in serum (-60 pM). The transporters are
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therefore normally saturated with arginine in media, which explains why such high 
concentrations of analogues are needed to see a biological effect.
In addition, l-NMMA and l-NIO may also exert their effects by chelating iron, or 
directly inhibiting the transfer of electrons to cytochrome c (57).
However, in many systems, l-NMMA can increase murine T-cell proliferation that 
has been inhibited by RNI-producing cells (58-60), indicating that it may be able to affect 
RNI production without inhibiting the underlying cellular activity.
RNI production may also be inhibited by reducing the concentration of L-arginine 
in the medium or depleting arginine in medium with arginase (40,47,61-64). Up to one 
third of all the arginine taken up by a macrophage is used for RNI production (63), and 
any reduction in the rate of uptake will reduce the production or RNI.
1.5.2 Reduction of reactive RNI concentrations
RNI may be mopped up by adding excess iron (40), which chelates NO, and 
releases it only slowly (28), However, NO bound to iron also has chemical reactivity of its 
own as NO" (28), so this treatment is likely only to shift the balance of the different RNI, 
rather than remove RNI totally. Mixing iron with ascorbate, though, produces superoxide 
which can react with nitric oxide to produce peroxynitrite. Peroxynitrite has a very short 
half life in biological media, and in some instances this process inhibits the effects of RNI.
RNI may also be mopped up by haemoglobin (65,66). In this system, NO reacts 
with the oxygen in the iron-containing centre of haemoglobin to produce the stable nitrate 
anion and met-haemoglobin (33). This reaction forms the basis of the haemoglobin 
detection method for RNI and has been used to determine the role of RNI in Trypanosoma 
briicei infection (55,66) which is described later in this introduction.
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1.6 The role of RNI in Leishmania infection.
RNI play a fundamental role in the protective murine immune response to 
Leishmania. It is believed that they are the final effector molecules in a T,,1-type immune 
response. There is a wealth of evidence, both in vivo and in vitro, supporting this view. 
This section will explain the in vivo evidence that RNI are important, then the evidence 
that the role that they play is as a final effector molecule.
1.6.1 In vivo RNI production.
RNI production from iNOS in vivo is important in the production of a protective 
immune response \.o Leishmania. In Leishmania resistant mice, RNI production may be 
inhibited either by the injection of the arginine analogues i.-NMMA (67) into the footpad, 
or by the inclusion of l-NMMA in the animals’ drinking water (68). C3H/HeN mice fed 
L-NMMA and then challenged in the footpad with L. major, produced less RNI, (detected 
as nitrite and nitrate in urine), had larger footpad swelling, and a greater parasite burden in 
draining lymph nodes than control mice (68). CBA/T6T6 mice injected with L-NMMA 
directly into the footpad had a smaller footpad swelling than those injected with the 
biologically inert enantiomer o-NMMA or phosphate buffered saline (PBS) (67).
Targeted disruption of the iNOS gene also led to an increase in susceptibility to T. 
major, measured both as footpad swelling and as parasite burden in the footpad (69)
1.6.2 In vitro RNI production and leishinanicidal activity.
In vitro Leishmania infection of murine macrophages has revealed that 
macrophages can produce RNI and kill the parasites. Many different stimuli in many 
different macrophages can induce RNI production and leishinanicidal activity. In all
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systems where both have been measured together, the two effects correlate with each 
other, (as summarised in Table 1.3). Different stimuli for macrophages can produce 
different responses (70), but it is only those stimuli that induce production of RNI that 
cause the macrophages to kill Leishmania.
In addition the amount of RNI produced by peritoneal macrophages from different 
in-bred strains of mice in response to IFNy correlated with the ability of the mice to resist 
infection (71)
Those sets of cytokines described in Table 1.3 are the only ones for which a direct 
comparison has been made between RNI production and leishinanicidal activity. Many 
other stimuli can induce RNI production e.g. IL -la  (72), GM-CSF and TNFa (73), IFNa 
and IFNp (70), BCG (74), TNFa or TNFp in synergy with IFNy (70). Others still can 
inhibit RNI production, most notably ÏL-4 (37), IL-10 (75,76), and TGF|3 (77). lL-4 can, 
however, synergise with IFNy to stimulate leishinanicidal activity of macrophages (78), 
though it should be noted that its effects on RNI production depend very much on the 
timing of the exposure of the macrophage to IL-4 and the stimulating agent (Feng, G.-J., 
personal communication). It is surprising that no attempt has been made to correlate the 
cytokine inhibition of RNI production with an inhibition of leishinanicidal activity in 
murine macrophages.
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Table 1.3: Stimuli for RNI production and leishinanicidal activity by macrophages.
Stimulus Macrophage cell type Ref
IFNy +L. major or LPS. Inhibitable 
with l-NMMA or anti-TNFa
Resident peritoneal cells. (79)
IFNy inhibitable with L-NMMA Resident peritoneal cells (62)
IFNy inhibitable with l-NMMA Peritoneal exudate cells. (67)
TNFa inhibitable by l-NMMA Peritoneal exudate cells (80)
IFNy + TNFa Peritoneal exudate cells (81)
IFNy + LPS, inhibitable by l-NMMA 
or guanidine.
MAF + LPS, inhibitable by depleting 
L-arginine.
Peritoneal exudate cells and bone- 
marrow derived macrophages
(64)
IFNy + LPS, inhibitable by l-NMMA 
or anti-TNFa
Resident peritoneal cells and bone- 
marrow derived macrophages
(82)
Ca^" ionophore A23187 + LPS, 
inhibitable by l-NMMA or depleting 
L-arginine
Bone-marrow derived macrophages (40,41)
A23187 + IFNy Bone-marrow derived macrophages (83)
IFNy + LPS Bone marrow derived macrophages (54)
IFNy + Lipophosphoglycan J774 cell line (84)
IFNy + LPS, inhibitable by 
glycoinositolphospholipids
J774 cell line (85,86)
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1.6,3 Studies on the factors required for iNOS induction compared to those for 
resistance to Leishmania»
CD4" T-cells can be divided into at least two subsets, T,,l or T,,2, according to their 
cytokine secretion pattern in in vitro culture. T,,l cells secrete IL-2, IFNy and TNFp, T,,2 
cells secrete IL-4, IL-5 and IL-10, while they both secrete IL-3, GM-CSF and TNFa (87, 
and reviewed in 88). They are presumed to come from the same progenitor, the T„0 cell, 
and differentiate into their respective subsets during an immune response.
As described above, the cytokines required to stimulate RNI production from 
murine macrophages come primarily from the T,,i response, while the T,,2 cytokines 
inhibit RNI production. There is a wealth of evidence (15,89) to show that a T,,l response 
is protective in murine leishmaniasis, while a T,,2 response is not, and this correlation is a 
major reason for believing that RNI are part of the protective immune response to 
Leishmania. This section will therefore deal with the evidence that resistance to cutaneous 
leishmaniasis is dependent upon CD4" T cell responses, and then that it is dependent on a 
T,,l response.
1.6.3.1 The importance of T-cell responses in leishmaniasis.
The evidence for B-cells playing a role in the protective response to leishmaniasis 
is slim. Complement-mediated lysis of L. donovani promastigotes and their uptake by 
macrophages can be enhanced by antileishmanial antibodies (90), and F.^ , fragments of an 
anti-LPG monoclonal prevented establishment of L. major infection in susceptible 
BALB/c mice (91). Other parasite-specific monoclonals could protect against L. m. 
mexicana (92), L. major or L. m. amazonensis infection (93).
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This implies that a sufficiently high nnii-Leishmtmia antibody titre could affect 
parasite survival in a susceptible host. However, the natural immune response does not 
appear to rely on antibodies. Antibody levels or isotype differences in murine cutaneous 
infection of different mouse strains do not correlate with resistance to L. tropica (94). 
Passive transfer of serum or antibody fraction from immune mice does not affect infection 
of BALB/c mice (95). In addition, Biozzi AB/L mice, which have defective antibody 
responses, are still resistant to L. major infection (96). Although one group reported that 
B-cell depletion exacerbated the disease, resistance to the disease was restored by T cells 
alone, and the authors concluded that the B-cells were simply required for an effective T 
cell response (97). Later attempts at B-cell depletion, however, did not confirm the 
original finding (98), and in BALB/c mice, B-cell depletion reduced the infection rather 
than exacerbating it (99).
In contrast to experiments with B-cells, the evidence for T-cell involvement is 
strong. Athymic nude CBA or C57BL/6 mice, which are T-cell deficient are susceptible 
to L. major ox L. tropica infection (100) and adoptive transfer of syngeneic T-cells to these 
mice restores their ability to resist infection (100). Thymectomised, or irradiated mice 
also display reduced ability to resolve disease (101). Protective immunity can also be 
transferred to susceptible mice from syngeneic mice that have cured a primary infection 
with simply the T-cell population (102), and transferred from susceptible mice that have 
been protectively immunised against infection to syngeneic naive recipients (103).
Thus protection ngmnst Leishmania infection is dependent upon T-cell responses.
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1.6.3.2 The role of CD4" cells in protective immunity
The evidence that CD4" cells are primarily responsible for controlling infection 
comes also from adoptive transfer experiments. CD4" cells from resistant mice that have 
resolved a primary infection can transfer immunity to naive recipients (102-104). It is 
possible to immunise susceptible BALB/c mice with repeated intravenous or 
intraperitoneal injections of irradiated, heat-killed or sonicated promastigotes (95). This 
immunity was transferable to naive BALB/c mice by the CD4" population only (103).
However, not all CD4" responses are effective in clearing infection. In fact, an 
incorrect T cell response can be detrimental. For instance, susceptible BALB/c mice can 
be made resistant to infection by whole-body y-irradiation, anti-CD4 or cyclosporine A 
treatment (105-107). These mice mount a CD4" protective response which can be 
transferred to naive susceptible mice, but CD4" cells from naive susceptible mice can also 
transfer susceptibility to resistant mice (105). CD4" T-cell lines from BALB/c mice could 
also suppress protective immunity in resistant and immunised susceptible mice (108,109).
1.6.3.3 T,,l and T,,2 responses in iininiinity
It was soon realised that the reason for the differences in CD4" responses was due 
to the ability of CD4" cells to produce either a T,/I or a T,,2 type response. These 
differences in CD4" responses could account for the differences in susceptibility to 
experimental L. major infection (110,111). T,,l responses predominate in L. major 
resistant C57BL/6 mice, whereas in susceptible BALB/c mice, a T,,2 response 
predominates (111). Adoptive transfer of T-cell lines that express T,,l or T,,2 cytokines 
can also provide evidence for the role of a T,,l/T,,2 balance in regulating L. major 
resistance (112). IL-2 and IFNy secreting cells transfer resistance, while IL-4 secreting
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cells transfer exacerbation in both BALB/c and SCID mice (113). However, there was a 
single report of a T,,l cell line that confers susceptibility (108).
Further evidence for a role for the T,,l response in resistance to infection comes 
from cytokine depletion studies. Resistant C3H/HeN mice can be made susceptible by 
IFNy depletion using a neutralising IFNy monoclonal antibody (114). And anti-IL-4 
treatment of BALB/c mice confers protection on them, since it decreases the IL-4 response 
(115). The production of another T,,2 cytokine, IL-10, also correlates with susceptibility to 
leishmaniasis, since mRNA for it can be found in the draining lymph nodes of susceptible 
mice ( i l l ) .  However, neutralisation of this cytokine did not affect the progression of 
disease in BALB/c mice (116).
Transgenic and knockout mice have also been important in providing evidence for 
the importance of a T,,l response. 129/Sv mice, which are normally resistant to 
leishmaniasis could be rendered susceptible by overexpression of IL-4 (117), or by 
targeted disruption of the IFNy-receptor (118). Disruption of the IFNy gene in C57BL/6 
mice causes the immune response to default to a T„2 pathway, and the mice become 
susceptible to L. major infection (119). Normally susceptible IL-4 knockout mice, 
however, are able to control L, mexicana infection (120), though the gene disruption has 
no effect on their ability to clear L. donovani infection. IL-4 knockout BALB/c mice are 
also able to resist infection with L. major (121), and although another group reported that 
IL-4 knockout BALB/c mice were still susceptible toL. major infection, the knockout 
mice still did not show the rapidly progressive disease of the control mice (122).
So a T|,l response is important for the in vivo resolution of Leishmania infection,
but the cytokines alone are not sufficient to cure the infection since iNOS knockout mice
have an increased T,,l response, but are still unable to cure an L. major infection (69). As
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described above, in vitro iNOS production by macrophages is induced by cytokines 
and inhibited by T,,2 cytokines, suggesting that the final effector mechanism may be this 
induction of iNOS.
1.6.4 Other macrophage defence mechanisms.
Further evidence for the role of RNI as a final effector mechanism of the T,,l 
response io Leishmania comes from in vitro experiments which show that the other 
defence mechanisms of murine macrophages are not particularly effective.
Infected bone marrow-derived macrophages can kill L. major if stimulated with 
IFNy and LPS, which induce RNI production (54). However production of the oxidative 
burst for example by zymosan in bone marrow derived macrophages does not correlate 
with killing (54,64). Furthermore, it was not possible to inhibit toxicity using superoxide 
dismutase, and superoxide production actually slightly inhibited killing (54). Though 
killing of L. donovani (123) and L. major (81) correlated with production of reactive 
oxygen intermediates (ROI), this production of ROI increased with the addition of \- 
NMMA, while killing decreased (81), indicating that the two processes were separable.
Other components of macrophage defence are also ineffective. Even in an 
unstimulated macrophage, Leishmania live in an acidic compartment that has many of the 
lysosomal degradative enzymes in it (16). It is formed by the fusion of phagocytic vacuole 
containing the parasite with secondary lysosomes (124-126). The parasitophorous vacuole 
contains both macrophage- and Leishmania- derived products. The macrophage derived 
products include acid phosphatase, arylsulfatase, and trimetaphosphatase (127), cathepsins 
B, D, H and L, p-glucuronidase (128,129), and macrophage acid phosphatase (128). The 
parasite does not inhibit the acidification of the vacuole (128), but instead is best adapted
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to growing at this pH in the amastigote form (25). This acidification, however, is 
important for killing in an activated macrophage, since inhibition of the acidification using 
bafilomycin A i inhibited leishinanicidal activity (130).
Finally, evidence for a toxic role of RNI comes from the fact that RNI can be 
directly toxic to Leishmania. Addition of SNAP (54), or culturing the parasites in 
acidified nitrite (64) is toxic to theL. major andL. enriellii promastigotes.
RNI are not solely involved in the response io Leishmania infection. They are 
involved in the response to myriad other organisms (reviewed in 26,42,138), including 
intracellular organisms (43,44,52,131-133), extracellular organisms (55), viruses (45), 
bacteria (47,134,135), worms (136), and fungi (137). RNI are therefore a quite universal 
toxic mechanism.
1.7 RNI production by humans
Until now, I have concentrated on murine production of RNI since this is the 
system in which RNI production by immune system cells is best understood. However, 
INOS has also been found in bovine (139), rat (140,141), rabbit (141), and human cells 
(58,142-144).
However, while it has proved simple to get detectable levels of RNI from murine 
macrophages, it has proved harder in human cells. Comparing human and murine 
peritoneal macrophages with similar stimuli, it was possible to induce detectable RNI from 
mouse and not human cells (145,146). However, there have been reports of detectable 
RNI from human peripheral blood mononuclear cells (73,147), and in a rheumatoid 
arthritic joint, it was possible to detect co-staining of human iNOS with the macrophage 
markers nonspecific esterase and CD68 (143).
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However, the human response to L. donovani infection does correlate with ROI 
production (148,149). There is, however, an oxygen-independent killing mechanism as 
well, since macrophages from patients with Chronic Granulomatous Disease (CGD), 
which lack an efficient respiratory burst, are still able to kill the parasite (149), albeit not 
as efficiently as control people.
The T|,l/T,j2 dichotomy is also not as clear in the human disease as in mice, since 
self-healing cutaneous lesions often contain mRNA for IFNy, lL-4, IL-5 and IL-10 at the 
same time (150). In addition, during a fulminating visceral infection ofL. donovani, 
humans often produce extremely high levels of IFNy (150). The mouse model may also 
be very different from the human since the same species of parasite cause different disease 
severities in the different mammals.
Currently, not enough is known therefore about the human system to extrapolate 
from the murine experiments to say that RNI play a fundamental role in the human 
response to Leishmania.
1.8 Delivery of RNI to the parasitophorous vacuole
RNI may enter the PV as any of the neutral molecules in the group, many of which 
are neutrally charged, and thus are able to diffuse freely through lipids as well as water. 
Still, some nitrosothiols have been described as possible transporters of RNI, eg S-nitroso- 
cysteine or S-nitroso-glutathione (GSNO), which are formed when NO" reacts with 
cysteine or glutathione (151).
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1.9 Possible targets for RNI
1.9.1 Primary chemical targets
RNI have diverse reactions, and can react with several different targets in cells. 
These include iron, sulphydryl groups, amine groups, tyrosine residues, lipids, sugars and 
oxygen.
1.9.1.1 Iron
RNI affect many enzymes with iron sulphur centres. Inhibition of complexes I and 
II of the mitochondrial electron transport chain has been described both as targets of 
activated macrophages (152) and in cells treated with authentic NO gas in vitro (153). NO 
inhibited Og uptake that was dependent on malate and succinate, but not a -  
glycerophosphate or tetrametliylphenylenediamine, indicating that the inhibition was 
specific for complexes I and II in the transport chain. Mitochondrial aconitase, the rate 
limiting step in the Krebs cycle, is also inactivated by RNI (61,154-156). Cytosolic 
aconitase, however, is activated by the release of iron so that it binds iron responsive 
element motifs in DNA, decreasing the transcription of ferritin mRNA to regulate iron 
metabolism in murine elicited peritoneal macrophages (49)
The labile iron in the [4Fe4S]^" cluster may also be removed by oxidising RNI 
such as ONOO, leaving a [3Fe4S]'" cluster (157).
RNI can also react with iron in heme (158), found for instance in the cytochrome 
P430 family of enzymes (159) which includes NOS (160), cytochrome c oxidase, and 
superoxide dismutase. Different members of the family have different susceptibility to 
NO gas (158), and the inhibition is characterised by a fast, reversible inhibition of the
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enzyme, followed by a slow phase with variable reversibility. NO can also react with the 
oxygen in oxy-haemoglobin to produce nitrate and met-haemoglobin (33).
1.9.1.2 Siilpliydryl groups
S-nitrosothiols can be formed by any of the reactions shown in Table 1.2. They 
will prevent formation of disulphide bonds in proteins, and may inhibit DNA binding by 
many proteins that require sulphydryl groups for binding (29). This reaction is very 
common, and occurs under physiological conditions (161). Over 96 % of the RNI in 
human plasma was reported to circulate as S-nitroso adducts of proteins (162). S-nitroso- 
haemoglobin has been reported as playing a major role in maintenance of vascular 
pressure, and the nitrosation reaction has been reported to regulate the rate at which 
oxygen is released from haemoglobin (163).
Numerous example of RNI inhibiting enzymes through reaction with thiols have 
been described, including the NMDA receptor, cathepsin B, the calcium activated 
potassium channel, NADPH oxidase, G proteins/p21‘"‘ (164), adenylyl cyclase, bacterial 
membrane SH group target proteins, gIyceraldehyde-3-phosphate dehydrogenase (165), 
tissue plasminogen activator (166), aldolase, aldehyde dehydrogenase, y-glutamylcysteinyl 
synthetase, actin, AP-1 (167), NFkB (168), 0-methylguanine-DNA methyl transferase 
(169), and albumin (29).
S-nitrosylation can also increase the rate at which the cysteine residue is ADP- 
ribosylated (29,165), leading to a more permanent deactivation of the enzyme.
The half life of the nitrosothiol varies greatly from over 24 h for S-nitroso- bovine 
serum albumin to less than 1 h for SNAP (161). This means that many of the compounds 
could be considered to be “carriers” for RNI, or long-term stores. Furthermore, it provides
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evidence that RNI other than nitric oxide are involved in biological systems, since NO 
itself will not react with sulphydryl groups, while NO" or NO in the presence of oxygen 
will.
Once S-nitrosothiols are formed, they can directly donate the NO moiety to other 
sulphydryl groups (28), or they can release NO or NO" forming a sulphur radical or an RS 
group respectively. There is also evidence for them releasing NO (170). However, no 
detection method has yet been able to detect the formation of the RS radical that should be 
formed from release of NO, suggesting that they probably exert their effects by direct 
reaction with their targets.
1.9.1.3 Amine groups
RNI can react with primary amine groups on either DNA or proteins. The initial 
diazotisation reaction is common between the two:
R-NH2 + NO "> R-N=N" +H2O (171)
This intermediate can then either release nitrogen leading to deamination of the 
target, or cross-link the target to another organic molecule. Both reactions occur in DNA 
treated with RNI (171). Cross-linking requires the immediate proximity with another 
molecule and, in the case of DNA, this reaction occurs approximately six times slower 
than the deamination reaction (171).
Not all amine groups are equally reactive. The susceptibility of the different bases 
of DNA to deamination depends on the pH, whether the DNA is denatured, and the base 
sequence (171). At pH 4.2 adenine and guanine in RNA react at comparable rates, and 
cytosine slower, while in calf thymus DNA, guanine is deaminated faster than cytosine.
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which in turn is faster than adenine. This variabiliy makes it impossible to predict which 
bases are likely to be most affected in vivo.
RM increase the rate of mutation in DNA treated both outside cells (172-174) and 
in whole human cells (175). Damage to pancreatic islet cell^ treated with RM could not 
be inhibited by endonuclease inhibitors, suggesting that RM  may be acting directly on 
these cells’ DNA aS well (53). In addition, RM may also damage DNA indirectly, since 
they can inhibit DNA repair and synthesis enzymes (178).
Amines in amino acids are also susceptible, and RM  attack on the NH2 tenninus 
of hemoglobin has been reported (176), as well as on free amino acids (31):
Deamination and cross-linking are irreversible reactions, and any damaged 
molecules will need to be replaced rather than repaired by a damaged cell.
1.9.1.4 Tyrosine
The RM molecules peroxynitrite and NO2 can irreversibly react with the phenolic 
ring of tyrosine to produce nitrotyrosine (177). This nitration reaction may inhibit the 
phosphorylation of tyrosine, which is involved in intracellular signalling. In addition, this 
reaction may play a part in the inactivation of the ribonucleotide reductase both with in 
vitro inhibition using RM  donors (178) and in targets of macrophage activation (179,180). 
Ribonucleotide reductase catalyses the rate limiting step in DNA synthesis, and since 
macrophage cytostasis can be reversed by adding back deoxyribonucleosides (180), 
inhibition of this enzyme may be an important part of the RM attack.
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1.9.1.5 Oxygen depletion
RNI react with oxygen to produce nitrite and nitrate in biological solutions (28). 
There are many demands on the oxygen supply to a peripheral site of an immune response, 
including the rapid respiration of immune system cells, the production of a respiratory 
burst, and the fact that there is very little vascularisation of ^Leishmania lesion.
Production of RNI may therefore starve cells of oxygen.
To counteract this, RNI, in their capacity as the endothelium derived relaxing 
factor (65), have an arteriodilatory effect, thereby increasing the blood flow, and therefore 
the oxygen supply to tissues involved in an immune response,
1.9.1.6 Lipid peroxidation
Peroxynitrite rapidly oxidises lipids (181). The reaction is extremely fast and is 
diffusion limited. The free radicals formed by the peroxidation reaction set up a chain 
reaction that can spread throughout the lipid bilayer, similar to that caused by ROI. NO 
can form adducts that stop this chain reaction (181). The chain reaction can also be 
inhibited by glutathione with superoxide dismutase (182). However, both of these 
enzymes are also subject to attack by RNI, and may therefore be inhibited, allowing a 
chain reaction to continue.
Membrane components attached by glycosyl-phosphatidylinositol (GPI) anchors 
can also be removed by RNI (183). Such components on Leishmania include 
glycoinositol phospholipids (GIPLs), lipophosphoglycan (LPG), and the membrane 
protein gp63 (183).
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1.9.2 Secondary effects of RNI
1.9.2.1 Effects on proliferation and cell activation.
Proliferation of many cell types is inhibited by RNI (26,185). These include EMT- 
6 mammary carcinoma cells (61,72), fungi (63), murine skin cancer cells (184), murine 
splenocytes (60), peritoneal exudate cells (48), Trypanosoma cruzi (133). However, in 
some endothelial cells, low levels of RNI can enhance proliferation (186).
The toxic effects of RNI in vitro, however, do not always correlate with effects in 
vivo. For instance, T. brucei proliferation can be inhibited by RNI from macrophages in 
vitro (66), but under in vivo conditions RNI are not effective. Indeed the inhibitory effects 
of RNI on the immune system mean that in vivo inhibition of RNI production leads to 
reduced parasitemia (55).
RNI can also activate immune system cells. With human peripheral blood 
mononuclear cells, SNAP increased glucose uptake, altered the tyrosine phosphorylation 
pattern, increased NFkB translocation, and TNFa production (187). The effects could not 
be mimicked by 8-bromo-cGMP, a metabolically stable cGMP analogue, but the effects 
could have been due to G-protein activation (164).
The specific anti-proliferative effects of RNI could be due to inhibition of energy 
production, effects on intracellular signalling, or inhibition of ribonucleotide reductase 
which will inhibit production of DNA precursors without inhibiting production of RNA 
precursors.
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1.9.2.2 Cell death
RNI can stimulate apoptosis or c^use necrosis. Apoptosis is a programmed cell 
death in which the cell self-destructs, digesting its own cytoplasm, and then cutting up its 
DNA first into fragments several kilobases long, and then into fragments that are multiples 
of length that is wrapped around its histones (approximately 200 bp), forming a ladder if 
separated on an ethidium bromide gel (188,189).
Low concentrations of RNI can sometimes provide the signal for apoptosis in 
pancreatic p-cells (190), murine thymocytes (191), human epithelial cells and murine 
macrophages (192). How RNI provide the signal is unknown, but RNI treatment can be 
accompanied by an increase in Fas gene expression (191) which can provide the signal for 
apoptosis.
In contrast, higher concentrations of RNI can cause necrosis. Necrosis is a form of 
death caused by the cells losing their energy reserve, and being unable to maintain their 
osmotic balance. The cell swells and both internal and external membranes become 
disrupted (188,193,194). This effect is seen in oligodendrocytes (193) and cortical cell 
cultures (194) treated with high levels of RNI. In vivo evidence for RNI induced necrosis 
comes from inhibition of RNI production by l-NMMA during focal ischemia in the rat 
brain, where necrotic cell death was inhibited, but apoptotic death was not (195).
1.10 The interaction of RNI with ROI.
RNI can react with the ROI superoxide anion (O2') and hydrogen peroxide (H2O2) 
to produce peroxynitrite. Peroxynitrite is extremely short lived in biological solutions, 
with a half life of less than 1 s, since it is such a strong oxidant. It breaks down to the
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hydroxyl radical HO and NOy (181). Whether effects attributable to RNI are inhibited or 
exacerbated by ROI depends on the concentration of RNI, ROI, and the target reactions.
Instances in which the effects of RNI are exacerbated by ROI include lipid 
peroxidation (181), inhibition of aconitase (156), and the iron-sulphur centres of the 
electron transport chain (196). However, in other experiments, the effects of RNI can be 
inhibited by ROI, for instance the effect of NO gas on mitochondrial respiration of 
macrophages could be inhibited by FeSO/ascorbate mixture (153). FeSO^ on its own had 
no effect, suggesting that it was not mopping up the RNI.
RNI can also increase the oxidative capacity of ROI, increasing dihydrorhodamine 
oxidation by Oy (197), and lipid peroxidation (198). The chain reactions set up by lipid 
peroxidation, however, may also be inhibited by NO, indicating that the ratio of 
concentrations of NO:0y:target can heavily influence whether synergy or inhibition are 
important. In contrast, RNI can also inhibit the cyotoxicity of both superoxide and 
hydrogen peroxide (199).
1.11 Defence against RNI.
Leishmania have several mechanisms that can protect them from RNI. They can 
modulate the immune response to prevent the macrophage from producing RNI either by 
preventing the induction of a T,,l response, or by inhibiting the induction of RNI in the 
macrophage itself.
L. donovani infection of macrophages down-regulates expression of the 
costimulatory molecule B7-I (200), which means that macrophages are more likely to 
induce anergy than activation in T-cells. L. major infected macrophages also provide 
better stimulation to T;,2 cells than T,,l cells (38). Promastigotes from L. major and L.
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mexicaria and amastigotes from L. mexicana enter macrophages silently, without the 
macrophages producing IL-12, which would normally induce a T,,l type response. 
Amastigotes from L. major, however, do induce the production of IL-12 on infection of 
macrophages (201).
L. major can also down-regulate production of RNI by secreting GIPLs (84) or 
LPG (86) which inhibit transcription of iNOS. However, LPG can also synergise with 
IFNy to produce RNI if given after IFNy to murine macrophages (86), so the timing of the 
exposure to the different stimuli is important.
Though there have been no reports of Leishmania resistance to RNI itself, there are 
two strains of Mycobacterium intracellulare (46) and M. avium (50) that have been 
reported resistant (46), Brucella abortus is also resistant to RNI produced by macrophages 
(202). The mechanism of resistance is unknown, but could be the production of thiols, 
uptake of iron, or production of ROI.
1.12 Aims of this thesis.
This project aimed to characterise some of the biochemical pathways that are 
affected inL. m. mexicana amastigotes when they are treated with RNI, and examine the 
interaction of RNI with other components of the PV. The main aims were:
1. To develop suitable systems for producing RNI, and assessing their effect on 
the viability of axenically grown L. m. mexicana amastigotes.
2. To determine how RNI interact with other components of the parasitophorous 
vacuole, such as ^-glucuronidase, cathepsin D, and ROI, and whether this is 
important in the killing of L. m. mexicana.
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3. To determine whether L. m. mexicana amastigotes are particularly susceptible 
to RNI, and whether resistance could be induced by low levels of RNI.
4. To determine whether GIPLs, DNA or the mitochondria in live parasites were 
affected by RNI and whether they could be the primary targets of RNI.
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2. Materials and methods
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2.1 Materials
Chemical Supplier
[^H]-Glucosamine NEN Dupont, Stevenage, Hertfordshire, UK
['^H]-Methyl-thymidine Amersham International pic, Buckinghamshire, UK
1 -Propanol Lisons, Loughborough, UK
2,4-DinitrophenoI Sigma, Poole, Dorset, UK
96 % Ethanol Western Infirmary, Glasgow, Scotland
Acetic acid Fisher Scientific International, Loughborough, UK
Agarose Biogene Ltd, Kimbolton, Cambridgeshire, UK
a-Naphthy lamine Sigma, Poole, Dorset, UK
Araldite Agar Scientific
Autoradiography films Sigma, Poole, Dorset, UK
Benzyl penicillin Sigma, Poole, Dorset, UK
Boric acid Fisher Scientific International, Loughborough, UK
Chloroform BDH Ltd, Poole, Dorset, UK
Culture plates (24 and 48 well) Costar, Cambridge, Massachusetts, USA
Disodium hydrogen phosphate BDH Ltd, Poole, Dorset, UK
Dithioerythritol Boehringer-Mannheim, East Sussex, UK (from 
diluting enzyme buffer L)
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DNA molecular weight markers Gibco BRL, Paisley, Scotland
DNA polymerase (Kornberg 
fragment)
Boehringer-Mannheim, East Sussex, UK
DNase 1 Boehringer-Mannheim, East Sussex, UK
Ecoscint scintillation fluid Fisher Scientific International, Loughborough, UK
Enhance spray NEN Dupont, Stevenage, Hertfordshire, UK
Ethidium bromide Sigma, Poole, Dorset, UK
Ethylenediaminetetraacetic acid 
(EDTA)
Sigma, Poole, Dorset, UK
FACSFlow Becton Dickinson, Cowley, Oxford, UK
Fluorimeter 96 well plates Porvair filtronics. King’s Lynn, Norfolk, UK
Foetal calf serum (FCS) For J774 - Gibco BRL, Paisley, Scotland
For L. m. mexicana promastigotes and amastigotes - 
Lab tech batch no. 206
Always heat inactivated by heating to 56°C for 45 
mill.
Formaldehyde BDH Ltd, Poole, Dorset, UK
Gentamicin sulphate Sigma, Poole, Dorset, UK and The Wellcome 
Foundation, Beckenham, Kent, UK
Glass filters Whatman, Maidstone, Kent, UK
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Glutaraldehyde (25% grade) Sigma, Poole, Dorset, UK
Hemocytometers Weber Scientific International, Teddington, 
Middlesex, UK
HO MEM medium Prepared on site.
EMEM/Spinners salts plus L-glutamine, MEM 
amino acids, MEM non-essential amino acids from 
Gibco BRL, Paisley, Scotland. Sodium Bicarbonate 
and sodium pyruvate from BDH Ltd, Poole, Dorset, 
UK. Para-aminobenzoic acid, biotin, HEP ES from 
Sigma, Poole, Dorset, UK.
Horse Serum Gibco BRL, Paisley, Scotland
Hydrochloric acid (HCI) Fisons, Loughborough, UK
Interferon gamma (IFNy) A kind gift from Dr G. Adolf, Ernst-Boehringer 
Institut f r Arzinmittel-Forschung, Vienna, Austria
L-Arginine Sigma, Poole, Dorset, UK
i-Glutamine Gibco BRL, Paisley, Scotland
Lipopolysaccharide from 
Salmonella enieridis.
Sigma, Poole, Dorset, UK
Lithium chloride Sigma, Poole, Dorset, UK
L-Monomethyl arginine ( l -  
NMMA)
The Wellcome Foundation, Beckenham, Kent, UK
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Luminometer tubes Sterilin, Teddington, Middlesex, UK
Lu ri a Broth agar Gibco BRL, Paisley, Scotland
Magnesium chloride Boehringer-Mannheim, East Sussex, UK (from 
diluting enzyme buffer L)
Methanol Fisher Scientific International, Loughborough, UK
Minimal Essential Medium 
without arginine, cysteine, leucine 
methionine, inositol, glucose, or 
glutamine
Gibco BRL, Paisley, Scotland
Modified Diamond’s Medium Made on site using:
(MDM) Trypticase from Gibco BRL, Paisley, Scotland, 
Yeast extract from DIFCO, ascorbic acid, KCl, 
KHCO„ KH2PO4, K2HPO4, FeSO^.ZH^O from 
Sigma, Poole, Dorset, UK.
Nylon membrane for DNA Boehringer-Mannheim, East Sussex, UK
Nylon mesh Cadisch Precision Meshes Ltd, Finchley, UK
Opti-Flow Scintillation fluid Fisons, Loughborough, UK
Osmium tetroxide In-house supplies
Penicillin Gibco BRL, Paisley, Scotland
Phenol Blue Sigma, Poole, Dorset, UK
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Phenol/ chloroform/isoamyl Sigma, Poole, Dorset, UK
alcohol (25:24:1)
Phosphoric acid Sigma, Poole, Dorset, UK
Potassium Chloride (KCl) Sigma, Poole, Dorset, UK
Potassium dihydrogen phosphate Fisher Scientific International, Loughborough, UK
Proliferation plates (96 well) Nunclon, Roskild, Denmark
Propylene oxide Merck Ltd, Poole, Dorset, UK
Rhodamine 123 Sigma, Poole, Dprset, UK
Ribonuciease A Sigma, Poole, Dorset, UK
RPM I1640 medium Flow laboratories, Kent, UK
Salmon sperm DNA Sigma, Poole, Dorset, UK
Schneider’s Drosophila medium Gibco BRL, Paisley, Scotland
S-nitroso-N-acetylpenicillamine The Wellcome Foundation, Beckenham, Kent, UK
(SNAP)
Sodium borohydride Sigma, Poole, Dorset, UK
Sodium chloride Fisher Scientific International, Loughborough, UK
Sodium citrate Fisons, Loughborough, UK
Sodium dihydrogenphosphate BDH Ltd, Poole, Dorset, UK
Sodium hydroxide Fisher Scientific International, Loughborough, UK
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Sodium Lauryl Sulphate (SDS) Gibco BRL, Paisley, Scotland
Sodium nitrite (NaN02) Sigma, Poole, Dorset, UK
Sterilisation filters Gelman sciences, Ann Arbor, Michigan USA
Streptomycin Gibco BRL, Paisley, Scotland
Streptomycin Sigma, Poole, Dorset, UK
Sucrose BDH Ltd, Poole, Dorset, UK
Sulphanilamide Sigma, Poole, Dorset, UK
Syringe needles Becton Dickinson, Cowley, Oxford, UK
Syringes Becton Dickinson, Cowley, Oxford, UK
tetra-Sodium pyrophosphate BDH Ltd, Poole, Dorset, UK
Thin layer chromatography (TLC) Merck Ltd, Poole, Dorset, UK
Keiselgel 60 plates
Trichloroacetic acid (TCA) BDH Ltd, Poole, Dorset, UK
TRIS Gibco BRL, Paisley, Scotland
TRIS HCI Gibco BRL, Paisley, Scotland
Triton X-IOO Sigma, Poole, Dorset, UK
Trypan Blue BDH Ltd, Poole, Dorset, UK
Uranyl acetate Agar Scientific
Xylene cyanol FF Sigma, Poole, Dorset, UK
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2.2 Cell culture
2.2.1 Macrophages
J774 macrophages (from The Wellcome Foundation, Beckenham, Kent, UK) were 
cultured in tissue culture treated flasks in RPMI medium with 10% FCS (v/v) + l -  
glutaniine (2 mM), Penicillin (100 U/ml) and Streptomycin (100 pg/ml). The cells were 
subpassaged every 2-3 days by scraping the adherent monolayer off with a cell scraper and 
inoculating some of the cells into new flasks.
2.2.2 Leishmania
The strain of L. m. mexicana that was used was MNYC/BZ/62/M379.
2.2.3 Amastigotes
Amastigotes were cultured according to the method of Bates et al. (24), in 
Schneider’s Drosophila medium with 20% FCS (v/v) and gentamicin sulphate (25 pg/ml), 
pH 5,4-5.7. Amastigotes were subpassaged every 4-5 days by aspirating a portion of the 
culture through a 19G needle, and ejecting it through a 26G% needle. The cultures were 
grown at 32°C under air.
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2.2.4 Promastigotes
Promastigotes were cultured in HOMEM medium (203), prepared as follows by 
D. Laughland:
E-MEM/Spinners Salts with L-glutamine 1 Litre pack
Glucose 2 g
Sodium bicarbonate 0.3 g
Sodium pyruvate 0.11 g
y;m'fl-aminobenzoic acid 1 mg
Biotin 0.1 mg
HEPES 5.96 g
MEM amino acids (50x) 10 ml
MEM non-essential amino acids (lOOx) 10 ml
pH 7.4-7.S
Promastigotes were prepared by inoculating amastigotes into HOMEM with 10% 
FCS (v/v), and grown at 28°C in air. The culture was subpassaged every 3-5 days.
2.2.5 Tritrichomonas foetus.
T. foetus strain F2 was cultured at 37°C in Modified Diamond’s Medium (MDM) 
with 10% (v/v) Heat Inactivated Horse Serum and 1 mg ml ' streptomycin and 1000 U ml * 
benzyl penicillin. MDM was prepared as follows by D. Laughland:
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For 1 litre of MDM:
20 g Trypticase
10 g Yeast extract
5 g Maltose hydrate
I g L-Ascorbic acid
1 g KCl
1 g KHCO3
1 g KH2PO4
0.5 g K2HPO4
0.1 g FeS04.2Fl20
900 ml Water
pH 6.3-6.4
2.2.6 Escherichia coli and Salmonella typhimurium.
S. lyphimiirium strain BAD509 and E, coli .strain C600 were scraped off Luria 
Broth agar plates. The concentration was estimated using OD^ oo, assuming that OD6oo=0.2 
when they were at 10'" per ml.
2.3 Animal subpassage of L. m, mexicana.
BALB/c mice were infected subcutaneously in the rump with lO^T. m. mexicana 
amastigotes in HOMEM medium without FCS. After two months, when the lesion was 
visible, the mice were killed, and amastigotes prepared by pushing the lesion through a tea 
strainer into amastigote culture medium. Clumps of amastigotes were broken up by 
aspirating the suspension through a 190 needle into a syringe, and ejecting it through a 
260% needle. The suspension was centrifuged at 1600 g for 5 min at room temperature 
(RT), and resuspended in 5 ml culture medium. Clumps were broken up by pushing the
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suspension three times through a 26G% needle, and amastigotes were resuspended to 0.5 - 
2 X I O'' ml ' in 10 ml culture medium.
2.4 Tranforiiiation efficiency assay of amastigote viability
Amastigote viability was assayed by their efficiency of transforming to 
promastigotes. Amastigotes were inoculated into 500 pi or 1 ml of HOMEM with 10% 
(v/v) FCS, at a density of ^ lO'' ml '.
After 24 or 48 hr incubation at 28°C, many of the viable amastigotes had 
transformed to promastigotes. At this point, clumps were broken up by pushing the 
culture three times through a 26G% needle, and an aliquot of 100-200 pi was mixed with 
an equal volume of 4% formaldehyde in PBS to fix them. The numbers of parasites were 
counted on a hemocytometer. Cells were counted as promastigotes if they were > 5 pm in 
length, and had a flagellum at least as long as their body length. Thus a cell was only 
counted as viable if it had fully transformed to a promastigote. A sufficient number of 
squares were counted on the hemocytometer to include over 100 promastigotes in the 
control wells,
2.5 Measurement of RNI production
RNI production by macrophages and SNAP was measured by the accumulation of 
nitrite in the medium using the Griess reaction. The Griess reagent was made by mixing 
equal volumes of 0.1% (w/v) a-naphthylamine in water and 1% (w/v) sulfanilamide in 
5% (v/v) phosphoric acid. 100 pi of Griess reagent was added to 100 pi sample and after 
10 min the absorbance at 545 nm was measured on a Titertek Multiscan MCC 340 96-well 
plate spectrometer. In other experiments, the measurement was at 490 nm with a reference
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at 630 nm on a Dynatech MR5000 96-well plate spectrometer. Absorption spectra were 
measured on an LKB Ultrospec 4050 spectrophotometer.
2.6 Macrophage killing of amastigotes
Viable macrophages were counted using trypan blue exclusion (20 pi macrophages 
mixed with 80 pi of 4% (w/v) trypan blue in phosphate buffered saline pH 7.4 (PBS)), and 
cultured at 2 x 10'' ml ' in 1 ml medium in a 24 well plate. They were allowed to adhere at 
32°C, 5% CO2, for 2-3 h. Axenically grown amastigotes were centrifuged at 1600g for 5 
min at RT, and resuspended in 1 ml macrophage culture medium. The clumps of 
amastigotes were dispersed by pushing the suspension three times through a 26G% needle, 
and the amastigotes were resuspended to 2 x 10" ml '. The 1 ml medium of the 
macrophage cultures was replaced with 1 ml of this amastigote suspension (giving an 
infection ratio of 10:1). The amastigotes were allowed to infect the macrophages for 3 h at 
32°C, 5% € 02/95% air. The non-adherent amastigotes were then washed off the 
macrophages with three changes of warm RPMI without FCS, 1 ml of macrophage culture 
medium was then added. Adherent amastigotes were then allowed to invade the J774 cells 
by incubation overnight at 32°C, under 5% CÜ2/95% air.
Infected J774s were stimulated with lipopolysaccharide (LPS) (2 pg ml ') + 
interferon-y (IFNy) (500 U ml '), with or without l-NMMA (2 mM), and excess i-Arginine 
(2-10 mM). They were cultured for 48 h at 32°C under 5% C02/95% air. 100 pi of 
supernatant was then removed to measure RNI production using the Griess reaction.
The macrophages were then lysed to release the amastigotes using a variation on 
the method of Kiderlen and Kaye (198). The cultures were scraped in the 1 ml incubation
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medium using a yellow tip, and the suspension was then added to a 1.5 ml eppendorf.
Two washes of the wells with 250 pi of HOMEM without FCS were added to the same 
eppendorfs. Then 12.5 pi of 1% (w/v) SDS was added to the suspension. The suspension 
was centrifuged for 5 min at 1600 g RT, the supernatant removed, and 200 pi of 0.008% 
SDS in warm HOMEM without FCS was added to the pellet. The solution was left for 5 
min at 32°C, and the weakened macrophages were lysed by pushing the suspension six to 
seven times through a 260% needle.
The viability of the released amastigotes was then assayed by their transformation 
efficiency (see section 2.4).
2.7 Amastigote proliferation using pH]-Thyinidine.
Amastigotes were incubated at 1-2 x 10" ml ' in 100-200 pi of culture medium in 
96 well plates. Each well contained 1 pCi of [‘^ H]-thymidine. The plate was cultured for 
24 hr at 32°C under air, then harvested on a 1295 Beta-plate harvester (Wallac). 10 ml 
Betaplate scintillation fluid (Wallac) was subsequently added, and the filters were counted 
on a 1205 Betaplate counter (Wallac).
2.8 Treatment with S-Nitrosothiols.
Amastigotes at 5 x 10" ml ' were treated in 2 ml culture medium with freshly 
dissolved S-nitroso-N-acetyl penicillamine (SNAP). After 30 min, 10 ml HOMEM 
without FCS was added and the suspension was centrifuged at 1600g for 5 min at RT.
The culture was washed twice with 1 ml HOMEM without FCS, and resuspended in 1 ml 
HOMEM with 10% (v/v) FCS. Clumps of amastigotes were dispersed by passing the 
suspension three times through a 260% needle. Three aliquots of 50 pi were taken and the
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cell density determined immediately. The cultures were then incubated for 48 hr at 26°C 
under air in 24 well plates to assay transformation efficiency.
2.9 Treatment with Sodium Nitrite
RNI were produced by adding sodium nitrite to the amastigote culture medium. 
Since the medium was already acidic, this provided a very good method for producing 
RNI (see section 8.9).
The concentration of nitrous acid (HONO) in the solution could be calculated 
using the formula:
[HONO] = N dium  nitrite added]
' l , 1 0 ( p H - 3 .4 ) '
This formula was derived using the following series of equations:
NO; + H+ — .... " HONO (Eqn 2)
Which means that the K„ is defined by:
(Eqn 3)
The pK„ for HONO is already known:
P^ a(iioNO) “ 2.4 (Eqn 4)
By definition:
K. = lO-i""» (Eqn 5)
4 5
:> ] .  IQ-'" (Eqn 6)[HONO]
The concentration of HONO present can be calculated, given that the pH and the 
total sodium nitrite added were known. To do this, it is necessary to express [NO  ^] in 
terms of [total sodium nitrite added] and to express [H j^ in terms of the pH.
Assuming that the concentration of RNI is small compared to the concentration of 
the nitrite anion and HONO:
[NO2] = [total sodium nitrite added] - [HONO] (Eqn 7)
And by definition:
[H*] = 10'” P^) (Eqn 8)
So, by substitution of these equations into Eqn 6:
,,  ([total sodium nitrite added] - [HONO]) x 10^=>10-’ ■ = ^
Which can be rearranged to give:
10  ^ ([total sodium nitrite added] - [HONO]) 
_> = [HONO]
By further rearrangement, we get:
...(nii-M) [total sodium nitrite added] , _
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. > ______« * '" '- 0 ------------------ ! _  ,E ,„ ,2,[total sodium nitrite added] [HONO]
IE,. B ,
Which is the same as Eqn 1.
2.10 Measurement of ATP levels.
ATP was measured using a method based on Churchill el al (204) and Strehler 
(205). Amastigotes were cultured at 2 x 10  ^ml ' in medium containing HONO. To lyse 
the cells, 100 pi of culture was rapidly mixed with 900 pi of ice cold 5.56% (w/v) TCA in 
water. The sample was kept on ice, and then centrifuged at 13000g for 20 min at 4''C to 
remove the precipitated protein. 500 pi of the supernatant was neutralised with 55 pi of 3 
M KOH/0.4 M Tris/0.3 M KCL 50 pi of this was warmed to 25°C in a water bath, and 
mixed in a luminometer tube with 50 pi luciferase reaction mixture prepared from a kit 
from Sigma. Light emissions were measured in a Wallac LKB 1250 luminometer, and 
readings were integrated over the period 30 to 40s after mixing the sample with the 
reaction mixture.
2.11 Measurement of Rhodamine 123 uptake.
A Becton Dickinson Fluorescence Analysis Cell Sorter (FACS) was used in all 
experiments. Amastigotes were filtered through a 100 pm nylon mesh at the start of the 
experiment to prevent debris from clogging the FACS.
Amastigotes were cultured at 2 x 10" ml ' in culture medium containing 13 pM 
Rhodamine 123. At each time point, 20 pi of the labelled suspension was put into 980 pi
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FACSFlow buffer and immediately acquired on the FACS. 2000 amastigotes were 
normally acquired.
2.12 Labelling and preparation of glycoinositol phospholipids (GIPLs).
2.12.1 Labelling:
GIPLs were labelled by incubating 4x10^ amastigotes in 4 ml Minimal Essential 
Medium (MEM) containing 100 pCi/ml of ['^H]-glucosamine, pH 5.5 for 4 hr.
2.12.2 Extraction:
GIPLs were extracted by centrifuging the amastigotes at 12000g for 5 min at RT, 
and resuspending in 500 pi of a mixture of chloroform/methanol/water (1:2:0.5). The 
suspension was vortexed, sonicated, and left for over 2 hr at RT. The mixture was 
centrifuged at 12000g for 5 min at RT, and the pellet extracted again. The extract was 
dried under nitrogen.
2.12.3 Purification:
GIPLs were desalted by resuspending in 300 pi of water-saturated butanol, and 
adding 100 pi water. The mixture was vortexed, and centrifuged at 12000g for 15 s at RT. 
The top phase containing the GIPLs was removed, and the water phase again extracted 
with a further 300 pi butanol. The mixed butanol phases were then back-extracted with 
200 pi water. The GIPLs were then dried under vacuum, and resuspended in either 3M 
sodium acetate buffer pH 4.0 or amastigote culture medium.
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2.12.4 Treatment with RNI:
GIPLs were incubated for 24 hr at 33°C in nitrite acidified with sodium acetate (pH 
4.0) or amastigote culture medium in a final volume of 22.5 pi. 5 pi 0.4 M boric acid was 
then added and neutralised to pH 9 with 2 M sodium hydroxide (approximately 3 pi). The 
carbohydrate aldehydes released were reduced by adding 10 pi sodium borohydride in 1 
mM sodium hydroxide, and incubating overnight at RT. The reduction was stopped with 
20 pi 1 M acetic acid, and the volume made to 100 pi with water.
2.12.5 Determination of the amount of deglycosylation:
The GIPL suspensions were extracted twice with 300 pi water-saturated butanol, 
and then the butanol phase was back-extracted once with 200 pi water, as described in the 
preparation procedure. The volumes of the phases were measured, and 10% of each phase 
was assessed for radioactivity using 5 ml Ecoscint scintillation fluid in a Minaxi Tri-Carb 
4000 series scintillation counter.
2.13 Electron microscopy
Samples for electron microscopy were processed, sectioned and stained by 
Margaret Mullen and Dr Lawrence Tetley.
0.2 M phosphate buffer pH 7.4 was made by the addition of 19 ml of 27.2 g/I 
potassium dihydrogen phosphate and 81 ml of 28.4 g/1 disodium hydrogen phosphate.
Amastigotes at 2 x 10" ml ' (axenically cultured or fresh from a lesion) were 
cultured with various concentrations of sodium nitrite or 2,4-dinitrophenol, and at each 
time point, 3 ml was spun at 1600g for 5 min at RT. The pellets were fixed in 2.5% (v/v)
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gliilaraldehyde in 0.1 M phosphate buffer for 30 min at RT. The sample was then washed 
with 1ml 0.2 M phosphate buffer, and placed in 1% osmium tetroxide for 1 h. After 
washing three times in distilled water over 30 min, it was placed in 0.5 % uranyl acetate 
for 1 hr in the dark, and then rinsed with distilled water. The sample was dehydrated in 
gradually increasing concentrations of ethanol (30%, 50%, 70%, 90%, Absolute (twice). 
Dried Absolute Ethanol) for 10 min in each wash.
The sample was washed for five minutes three times in propylene oxide, and 
embedded in propylene oxide/Araldite (1:1).
Araldite:
10 ml Dodecenyl succinic anhydride
10 ml Araldite CY212
0.4 ml Benzyldimethylamine
After drying overnight in a rotator, the samples were embedded in fresh Araldite 
and baked at 60°C for 48 hr. They were sectioned on a Reichert:Jung Ultratome into 60- 
80 nm sections onto copper grids, and stained with 2% methanolic uranyl acetate for 5 
min. Samples were viewed on a Ziess 902 transmission electron microscope.
2.14 Oxygen uptake measurement
Amastigotes (axenically cultured or fresh from a lesion) were cultured at 2 x lO*" 
ml ' in a 70% ethanol-sterilised temperature-controlled chamber. Readings were taken 
with a model 1302 oxygen electrode and recorded on a 781B oxygen meter, both from 
Strathkelvin Instruments. An SE120 pen recorder from Belmont Instruments recorded the 
trace, with the paper moving at 12 cm/hr. Rates of oxygen consumption were measured at 
a given time after addition of the sample in to the chamber (usually 20 min). Calibration
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was by bubbling air through the medium to achieve 100% saturation, and 0% oxygen was 
measured using a dilute solution of sodium sulphite.
2.15 DNA assays
All methods were based on Sambrook el a l (206), Promega protocols and 
applications guide 1990, and Fehsel el al. (53)
2.15.1 Buffers used:
TELT buffer:
50 mM Tris HCl pH 8.0
62.5 inM EOT A pH 9.0
2.5 M lithium chloride 
4% v/v Triton X-100
TE buffer:
10 mM Tris HCl pH 7.5 
1 mM EDTA
Gel Loading buffer:
25 mM Tris HCl pH 7.5 
1 inM EDTA 
40% (w/v) sucrose 
0.025% (w/v) Phenol Blue 
0.025% (w/v) xylene cyanole FF
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20 X SSC
175.3 g r ' sodium chloride
88.2 g r ' Sodium citrate 
pH 7.0
5 X Tris/Borate/EDTA (TBE) buffer (in 1 litre)
54 g TRIS base
25.7 g boric acid
20 ml 0.5 M EDTA (pH 8.0)
2.15.2 Preparation of DNA from amastigotes:
0.5-2 X 10  ^amastigotes were centrifuged at 1600g for 5 min at RT, and lysed in 
500 pi TELT buffer. After 5 min incubation at RT, proteins were denatured and extracted 
with an equal volume of phenol/chloroform/isoamyl alcohol (ratio 25:24:1), and then once 
with chloroform. After precipitation with two volumes of 100% ethanol for 5 min on ice, 
and centrifuging at 13000 g for 5 min at 4°C, the pellets were vacuum dried and 
resuspended in TE buffer containing 20 pg/ml of pancreatic ribonuclease A. The DNA 
was left at 4°C overnight to rehydrate before measuring the concentration using either the 
ODj '^.t/ODjso ratio of a 1:50 dilution of DNA in a TE buffer on a Beckman 
spectrophotometer or using the fluorimeter (see section 2.15.3).
2.15.3 Fluorimeter measurement of DNA concentration:
2 pi amastigote DNA was mixed with 50 pi TE buffer containing 2 pg/ml ethidium 
bromide in a fluorimeter 96 well plate. A standard preparation of amastigote DNA was 
used, the concentration of which was determined using the OD^ g^ . Fluorescence was 
measured using a Perkin Elmer Luminescence Spectrometer LS50B with an excitation
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wavelength of 254 nm and an emission wavelength of 605 nm with a slit width of 15 nm. 
The integration time was 1 s, though there was little difference in the reading if 0.1 s or 10 
s were used (data not shown).
2.15.4 Nicking of DNA with DNase 1:
DNase 1 nicking buffer:
50 niM Tris HCl
10 niM Magnesium chloride
0.1 mM Dithioerythritol
0.3 pg amastigote DNA was mixed with DNase 1 and incubated for 2 hr at 37“C. 
A sample was then run on a 0.8% agarose gel, and a sample was added to the nick 
translation reaction.
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2.15.5 Nick translation:
Reaction mixture:
50 mM Tris HCl
10 mM Magnesium chloride
0.1 mM Dithioerythritol
56 pM dATP
56 pM dCTP
56 pM dGTP
56 pM dTTP
1 pCi [""P]-a-dATP
lU DNA polymerase (Kornberg polymerase)
Final volume: 20 pi
A typical reaction proceeded for 2 hr, and was stopped by putting 10 pi into 290 pi 
0.2 M EDTA for quantification using TCA precipitation. The rest of the reaction was 
mixed with 10 pi of a Gel Loading Buffer/0.2 M EDTA (ratio 3:7) for gel electrophoresis.
2.15.6 Detection of labelled DNA:
2.15.6.1 Trichloroacetic Acid (TCA) precipitation:
10 pi of the stopped reaction mixture (see section 2.15.5) was spotted onto a glass 
filter to measure the total radiation, and 10 pi was mixed with 90 pi denatured salmon 
sperm DNA To this was added 1.3 ml 10% (w/v) TCA/1% (w/v) letra-soûxum 
pyrophosphate. After 20 min on ice, the whole reaction was filtered through a glass filter, 
and washed three times with 5 ml 10% TCA/1% /c/ra-sodium pyrophosphate, then once 
with 5 ml 96% Ethanol. Both sets of filters were air dried, mixed with 5 ml Opti-Flow 
Scintillation fluid, and counted in a LS 6500 Beckman Scintillation counter.
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2.15.6.2 Electrophoresis:
Samples were run on a 0.8% 0.5 x TBE agarose gel containing 0.5 pg/ml ethidium 
bromide. Radioactive markers were made by adding 5 pi of the markers to 15 pi of the 
nick translation mixture. The gels were photographed, denatured in 0.4 M NaOH/1 M 
NaCl for 40 min, and blotted overnight onto a nylon membrane using 20 x SSC buffer and 
capillary action. The membrane was washed in 0.5 M Tris/1 M NaCl pH 7.5, then air 
dried and autoradiographed.
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3. Optimisation of assays for L. m. mexicana viability and in 
vitro production and detection of RNI.
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3.1 Introduction
To study the effect of RNI on L. m. mexicana amastigotes in vitro, both viability 
assays for the parasite and adequate methods of RNI production needed to be developed.
Methods for axenically culturing amastigotes from any species of Leishmania have 
only recently become available (23), so there are no standard viability assays for them. 
Assessment of amastigote viability in macrophages has either been by Giemsa staining of 
fixed macrophages (62,128), or by lysing the macrophages, transforming the amastigotes 
to promastigotes and assaying viability by [^H]-thymidine uptake (85,207), or MTT 
reduction (198). [Tl]-thymidine uptake and MTT reduction are used after transforming 
amastigotes to promastigotes, so have only been used to assess promastigote viability. 
Since promastigote metabolism is different from amastigote metabolism (208), an 
assessment of whether either of these methods was suitable for amastigote viability was 
required.
RNI detection and production with the equipment available required an assessment 
of the standard chemical reactions. The normal assay for the Griess reaction requires 
measurement at 540 nm (33), while the closest filters available for the departmental 96 
well spectrometer were 490 nm and 570 nm. Furthermore, the effect of some of the dyes 
(eg Phenol Red) in the media used on the absorption spectrum of the Griess reaction 
product needed to be assessed.
One method for production of RNI is the addition of S-nitroso-N-acetyl 
penicillamine (SNAP) to the medium. The release of RNI from this molecule can be 
affected by temperature, pH, presence of sulphydryl groups and metal ions (27,28), all of 
which are dependent on the medium and foetal calf serum (FCS) used. To determine the
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rate of RNI production for the systems used here, it was necessary to determine how 
SNAP interacted with the Griess reagents and amastigote culture medium.
Another method for RNI production is acidification of sodium nitrite to form 
nitrous acid, which then decays to form the other RNI (64). It was necessary to determine 
both the stability of this system and whether the toxicity of such a system was due to RNI 
production, to nitrite itself or to the sodium ions.
Finally, to study the mechanisms whereby J774 cells, a murine macrophage-like 
cell line, kill amastigotes, it was necessary to develop methods for stimulating the line to 
produce RNI at 32°C, and to develop a method for lysing the J774 cells to release intact 
amastigotes. This chapter describes the initial experiments to determine the optimal 
conditions for the viability assays, production and measurement of RNI in vitro, and the 
stimulation of J774 cells.
3.2 Development of viability assays
Two viability assays were studied - [^H]-thymidine uptake, and transformation 
efficiency. To show that the assays were suitable for L, in. mexicana amastigotes, it was 
necessary to show that increasing the concentration of amastigotes at the start of the 
experiment increased both [Tl]-thymidine uptake and the number of promastigotes after 
the transformation.
3.2.1 Thymidine assay
Amastigotes were cultured for 24 h in the presence of thymidine, as described in 
Materials and Methods. [Tl]-thymidine uptake increased with increasing initial 
concentrations of amastigotes up to 1 x 10^  ml ' (Figure 3.1). Since readings from
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thymidine uptake were obtainable down to 2 x 10  ^mb', most thymidine uptake 
experiments were performed at this concentration of parasites. Though the uptake of pH]- 
thymidine was much less, the readings were still high enough to give reproducible results.
3.2.2 Transformation assay.
Amastigotes are very different from promastigotes. The former are small ( 3x5  
pm), aflagellate, and non-motile. The latter are very varied in shape and size, but 
characteristically are flagellate, motile, and up to 60 pm in length. The protein and surface 
glycolipid profiles are also very different, and the transformation process involves a 
division step. This means that in order to transform to promastigotes, the amastigote must 
have its protein, glycolipid, and DNA synthesising systems intact.
The extracellular signals required to transform from amastigotes to promastigotes 
have not been clearly defined, but amastigote growth is sustained in Schneider’s 
Drosophila Medium, pH 5.4-5.7, with 20% (v/v) FCS at 32-33°C (24). Amastigotes will 
transform to promastigotes in HOMEM medium (203) containing 10% (v/v) FCS, and 
grown at 26-28°C (25). The transformation process can take 48 h, though often 24 h was 
sufficient. Because of the often rapid growth of promastigotes after transformation, it was 
preferable to sample the number of transforming promastigotes after 24 h.
Figure 3.2 shows that the number of promastigotes after transformation increased 
with increasing initial concentrations of amastigotes up to a starting concentration of Ix 
10’ mb'. In future experiments, it appeared that the transformation efficiency could vary 
greatly, so most transformation assays were set up at below 1 x 10  ^mb' to ensure that at 
the end of the assay, the promastigotes had not reached stationary phase.
59
Figure 3.1: f  H]-tIiymidine uptake by amastigotes
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[■^H]-thymidine uptake by amastigotes over 24 h was assayed at 32°C. Results are 
expressed as the mean ± SEM. The results shown are representative of two separate 
experiments.
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Figure 3.2: Transformation efficiency assay.
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Axenically cultured amastigotes were seeded at different concentrations in HOMEM 
medium with 10% (v/v) FCS, and cultured at 26°C for 48 h. A sample was then fixed, and 
the density of promastigotes was determined.
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3.3 Production and measurement of RNI.
3.3.1 Introduction
Several methods have been used for the production of RNI in vitro, including 
bubbling of nitric oxide gas through medium, addition of chemicals that produce RNI, and 
production from the enzyme nitric oxide synthase. One problem with most methods is that 
the half life of the production system is often extremely short (28), which is unsuitable for 
mimicking the in vivo situation where a population of macrophages will produce RNI over 
a period of many hours (160).
Another problem is the measurement of the concentration of RNI present. The 
only method suitable for quantifying the individual RNI species is electron spin resonance, 
which cannot give localised information on the concentrations of RNI that might surround 
a parasite in the parasitophorous vacuole (PV). Furthermore, the debate continues as to 
which of the RNI species account for most of the toxicity. In addition, the proportions of 
the different species of RNI are likely to depend upon the environment of the production 
system. The kinetics of the reactions between the different RNI are likely to depend on the 
redox potential, the pH, the concentration of sulphydryl groups and metal ions, the 
concentration of oxygen, and probably many other unknown factors.
The most common way to overcome this problem is to circumvent it, by adding a 
chemical that releases some RNI. Frequently S-nitroso-N-acetyl-penicillamine (SNAP) 
has been used, which releases NO and NO^ as well as reacting directly with other 
compounds. The amount of RNI present is then expressed simply as a concentration of the 
chemical added. A complication of this method is that the production of RNI from these
62
constructed in DMEM for measurements of the concentration of RNI in DMEM.
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compounds depends very much on the medium that is being used (209). Since amastigote 
culture medium is acidic, with the [H ]^ being almost two orders of magnitude higher than 
in other media in which these chemicals have routinely been used, the kinetics of release 
of RNI from SNAP were assessed using the Griess reaction which was first optimised for 
the system.
3.3.2 Absorption properties of the Griess reaction
Measurement of RNI production is often made by the Griess reaction. This 
involves the diazotisation of two aromatic amines, the progress of the reaction being 
measured by absorbance of the product at 540 nm. Since a 540 nm filter was not 
available, the suitability of other filters was assessed.
The absorption spectrum for the Griess reaction (Figure 3,3) shows that the 
absorption maximum of the product is 520 nm whether it is in DMEM, RPMI or water. 
Thus the dyes in the media do not affect the absorption maxima and minima, though in
■DMEM they may affect the absorption coefficient, so that standard curves should be
The filters that could be used on the Dynatech MR5000 spectrometer were 490 nm 
or 570 nm. The absorption coefficient at 490 nm was not far below that at 520 nm,
-ÿ
indicating that this may be a suitable filter (Figure 3.3). A reference wavelength of 630 
nm could be used to normalise for non-specific diffraction
In water there is no dye that may produce a background reading (Figure 3.4), but in 
DMEM the optical density below 560 nm may be affected by a dye that is present in the 
medium (Figure 3.5). Without a detailed chemical analysis it is impossible to say whether
macrophages or SNAP might affect the absorbance of this dye. Therefore, although the 
absorbance at 490 nm may be stronger, the absorbance at 570 nm is less likely to be 
affected by changes in this dye.
Therefore, absorbance at 570 nm was generally used with the Dynatech MR5000, 
and 545 nm with the Titertek Multiscan MCC 340 spectrometer.
3.3.3 Determination of the rate of release of RNI from SNAP
3.3.3.1 Release of RNI from SNAP in Griess reagent
To determine the rate of release of RNI from SNAP in any medium using the 
Griess reagent, it was necessary to assess RNI release from SNAP in the Griess reagent, 
which in turn required knowledge of how quickly the Griess reagent could detect RNI 
production. The Griess reagent responded very quickly to sodium nitrite (Figure 3.6), and 
the reading for a given concentration of nitrite stayed stable for almost two hours (Figure 
3.7). Therefore, if SNAP released RNI for several hours, which would be a suitable rate 
for analysing its effects on amastigotes, the Griess reagent would respond quickly enough 
to be useful in measuring the rate of RNI release from SNAP.
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Figure 3.3: Absorption spectrum for the Griess reaction.
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Sodium nitrite was dissolved to 72.5 a^M in 500 [xl medium and mixed with 500 |xl of the 
Griess reagent for at least 10 min at room temperature. The spectrum of the products was 
then determined. The results for the measurement in water are so close to those for RPMI 
that the symbols are hidden behind the symbols for RPMI.
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Figure 3.4: Absorption spectrum for the Griess reaction in water
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Sodium nitrite was dissolved to 72.5 pM in 500 pi water and mixed with 500 pi of the 
Griess reagent for at least 10 min at room temperature.
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Figure 3.5: Absorption spectrum the Griess reaction in DMEM
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Sodium nitrite was dissolved to 72.5 pM in 500 pi DMEM and mixed with 500 pi of the 
Griess reagent for at least 10 min at room temperature.
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Figure 3.6: The kinetics of the Griess reaction
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Serial dilutions of sodium nitrite were made in 50 |il RPMI, and mixed with 50 [a1 Griess 
reagent at RT.
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Figure 3.7: Stability of the Griess reaction
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Serial dilutions of sodium nitrite were made in 50 |Ltl RPMI, and mixed with 50 \x\ Griess 
reagent at RT.
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3.3.4 Release of RNI from SNAP in amastigote culture medium
SNAP does not immediately release all its RNI in the Griess reagents (Figure 3.8), 
so it is meaningful to use the Griess reaction to measure the rate of nitrite release from 
SNAP in culture medium.
The rate of release of RNI from SNAP in amastigote culture medium is nearly the 
same as the rate of release in Griess reagent (Figure 3.8 and Figure 3.9). 1 mM SNAP will 
release approximately I pM min ' nitrite in amastigote culture medium.
This meant that a solution of SNAP in amastigote culture medium would continue 
to produce RNI for a few hours. This is a reasonable length of time when compared to the 
several hours over which macrophages release RNI in culture. SNAP can therefore 
reasonably be used to produce RNI to assess the toxicity to L, m. mexicana amastigotes.
The rate of release of RNI release from SNAP was then measured in every 
experiment using SNAP.
3.3.5 The toxicity of SNAP to amastigotes.
SNAP is toxic to amastigotes in a half hour incubation (Figure 3.10). 1 mM SNAP 
usually killed just some of the cells, whereas 10 niM SNAP was normally lethal to all cells 
by 30 min. The toxicity was not due to the N-acetybpenicillamine (NAP) moiety of 
SNAP since NAP at 10 mM was not toxic.
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Figure 3.8: The rate of release of RNI from SNAP in the Griess reagent.
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SNAP was dissolved in RPMI with 20% (v/v) FCS, and placed in 50 pi in a 96 well plate. 
50 pi of Griess reagent was added, and compared to a standard of sodium nitrite.
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Figure 3.9: Rate of release of RNI from SNAP in amastigote culture medium.
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50 (il SNAP in amastigote culture medium was mixed with 50 fil Griess reagent at the 
times shown, incubated at RT for 10 min, and read at 540 nm against a sodium nitrite 
standard curve. Results are expressed as the mean ± SEM, and is representative of five 
separate experiments.
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Figure 3.10: The effect of SNAP on amastigotes
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Axenically grown amastigotes were treated with freshly dissolved SNAP or 10 mM NAP 
for 30 min at 32°C in air. Viability was assayed by transformation efficiency. Results are 
expressed as the mean ± SEM, and are representative of five separate experiments.
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3.4 Production of RNI using acidified nitrite
Another method for producing RNI in vitro is by acidification of the nitrite anion.
In distilled water, most of the reactions of such a solution can be attributed to RNI that 
behave like NO  ^(J. Reglinski, personal communication). However, in complex biological 
media, almost all of the RNI can be formed by the complex series of reactions involving 
sulphydryl groups and iron-containing enzymes.
A solution of acidified nitrite can form an equilibrium between the nitrite and RNI 
that is more likely to mimic the in vivo system of a steady production of NO by nitric 
oxide synthase (NOS) than simply adding SNAP (see section 3.6).
Acidified nitrite produces RNI by protonation of the nitrite anion to form nitrous 
acid (HONO). MONO will then spontaneously decay to form the other RNI. To prove 
that the toxicity of such a solution is due to RNI production rather than direct toxicity of 
the nitrite anion or the sodium ion, we compared the toxicity of a solution of nitrite at 
different pH’s (Figure 3.11).
In such a solution, the toxicity depends both on the concentration of nitrite and on 
the pH. It is possible, however, to calculate the concentration of HONO using the 
equations described in Materials and Methods (Section 2,9). The toxicity of the solution 
can thereby be shown to correlate with the concentration of HONO.
This does not mean that HONO is necessarily the toxic moiety in the solution, but 
rather that its calculated concentration correlates with toxicity (Figure 3.12). It is therefore 
a good measure of the concentration of whatever is toxic.
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Such a solution maintains most of its toxicity for at least 24 h (Figure 3.13). Thus 
the concentration of RNI after 24 h is only slightly lower than the concentration when the 
equilibrium is set up fresh. This is particularly important, because it is imperative not to 
study the toxic effects of an extremely high short dose of RNI, which may be different 
from the toxic effects of a long exposure to RNI.
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Figure 3.11: The toxicity of a solution of sodium nitrite depends on the pH.
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['’H]-thyniidine uptake by amastigotes was assayed in the presence of sodium nitrite in 
medium acidified with 1 M hydrochloric acid. Results are expressed as the mean ± SEM 
(n=4), and are representative of three separate experiments.
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Figure 3.12: The toxicity of a solution of sodium nitrite correlates with the 
concentration of nitrous acid (HONO).
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Data from Figure 3.11. Results normalised for the effects of pH on control proliferation, 
by taking the proliferation in the absence of sodium nitrite as 100 %. The concentration of 
HONG was calculated from the concentration of sodium nitrite and the pH. Results are 
expressed as the mean ± SEM (n=4), and are representative of three separate experiments.
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Figure 3.13: The effect of leaving the acidified nitrite solution for 24 h.
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Serial dilutions of sodium nitrite were made in amastigote culture medium, and either kept 
at 32°C in air overnight or used immediately. Amastigotes were added to a final 
concentration of 2 x 10^  ml ' in the presence of thymidine, and cultured for a further 24 h 
before harvesting.
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3.5 L, m. mexicana infection of J774 cells at 32°C
Assays of macrophage killing of amastigotes have either been based on 
microscopic examination of Giemsa-stained macrophages or lysis of macrophages 
followed by a viability assay such as [^H]-thymidine uptake or MTT reduction. One 
problem with Giemsa staining is that it is not possible to determine whether the 
amastigote is alive or dead. The major problem with many of the viability assays is that 
they do not distinguish between macrophages and Leishmania, so that if the macrophages 
are not completely lysed, the results could be attributed to the macrophages that are left 
rather than the parasites.
The transformation efficiency viability assay overcomes both these problems when 
used to measure the relative number of live or dead amastigôtes that could be recovered 
from a population of macrophages. This method does not give an absolute number of 
viable parasites per cell, but simply a relative measure of percentage viability between 
infected populations. Amastigotes takep from an unstimulated macrophage culture were 
therefore defined as 100 % viable.
Since there is only a small difference in the concentrations of sodium lauryl 
sulphate (SDS) that are required to lyse amastigotes from L, donovani and macrophages 
(198), a method for specifically lysing J774s rather than amastigotes was developed. This 
involved a combination of SDS and shearing induced by pushing the macrophage 
suspension through a 26GVg needle. The efficiency of the protocol was assessed by the 
final number of macrophages and the number of amastigotes recovered (Table 3.1).
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Having established that it was possible to lyse J774s without lysing T. m. mexicana 
amastigotes, the conditions required for J774s to produce RNI at 32°C were examined. 
Figure 3.14 shows that J774s could produce RNI and kill L. m. mexicana at 32°C. RNI 
production and some of the leishmanicidal activity could be inhibited by NOS inhibitor l -  
NMMA. More RNI was produced from 1774s stimulated with the high stimulus (500 U 
mO IFNy + 2 pg mb' LPS).
80
Table 3.1: Efficiency of the lysis protocol.
Treatment Macrophages in total Amastigotes
(i) Scraping wells with a yellow tip (5.3 ± 0.6) X 10' N.D.
(ii) (i) followed by centrifugation at 
I600g for 5 min at 23°C. 
Resuspend in 100 pi 0,1% SDS for 
a up to 15 min.
After 7 min: 4.3 x 10' 
After 10 min; 1.5 x 10' 
After 15 min: 2.9 x 10'
N.D.
(iii) (ii) followed by five times through 
a yellow tip.
1.9 X 10' N.D.
(iv) (iii) followed by 4 x through a 
26G’\  needle
1 X 1 0 ^ N.D.
(V) As (iii) followed by 3 x through 
26G'\ needle
5 x 1 0 ' N.D.
(vi) As (iv) but 0.01% SDS for 7 min. 1 X  1 0 ' 9x  1 0 '
(vii) As (iii), but before centrifugation, 
added 15 pi of 1% SDS
0  (n=2) 3.1 X lO'and 
3.7 X 10'
(viii) As (vii), but using 0.008% SDS, 
instead of 0.01% SDS
2 and 0 5.8 X 10' and 
5.4 X 10'
2 X 10^  J774 cells were infected overnight with 2 x 10'’ amastigotes as described in 
Materials and Methods. Cells were lysed as described, and the efficiency assayed by 
counting the number of amastigotes and 1774s immediately after lysis. N.D. - Not 
Determined.
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Figure 3.14: J774 macrophages can produce RNI and kill L. m. mexicana.
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J774s were infected with amastigotes, then stimulated for 48 h with either Low stimulus 
(40 U ml ' IFNy + 10 ng ml ' LPS) or High stimulus (500 U ml ' IFNy + 2 gg ml ' LPS) in 
the presence of 1 mM l-NMMA. J774s were lysed using protocol (viii) (Table 3.1), and 
amastigote viability was assayed by transfonnation efficiency. Results are expressed as 
the mean ± SEM (n=4).
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3.6 Conclusions
The viability assays, ['H]-thymidine uptake and transformation efficiency, are both 
suitable for use with amastigotes from L. m. mexicana (Figure 3.1 and Figure 3.2). ['H]- 
Thymidine uptake has the advantage that it is easy to use, and several different 
measurements can be made in the same experiment.
Transformation efficiency has the advantage that the results are unequivocally a 
measure of amastigote viability. For instance, unlike thymidine uptake, it will distinguish 
between death and a temporary inhibition of pyrimidine uptake across the membrane, or 
any effect on pyrimidine synthesis. Another advantage of this assay is that it can take a 
‘snapshot’ of viability, which is suitable for time course experiments of toxicity, whereas 
['H]-thymidine uptake requires a 24 h incubation. It is, however, a much more 
cumbersome assay.
Of the filters available for the Griess reaction, it is best to use 570 nm for 
absorption, and 630 nm for reference when detecting nitrite production, to ensure that 
there was no interference from dyes in the medium.
1 niM SNAP produces nitrite at a rate of approximately 1 pM min * in medium. 
These measurements were not confounded by a sudden release of nitrite when SNAP was 
added to the Griess reagent, or by the decay product of SNAP mopping up nitrite on 
addition of the Griess reagents, both of which scenarios are conceivable given the varied, 
and poorly characterised, reactions of RNI.
The high concentrations of SNAP (3 mM and 10 mM) required to kill amastigotes 
in 30 min released enough nitrite in that time for the nitrite itself to be toxic in the
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amastigote culture medium (compare the toxic concentrations in Figure 3.11 to the amount 
of nitrite released by 3 mM SNAP in Figure 3.9). This meant that the concentrations of 
the different RNI species would be changing constantly during the period of the exposure.
The toxicity of the solution of sodium nitrite, on the other hand, remains stable for 
up to 24 h (Figure 3.13). Since RNI is formed by an equilibrium between nitrite and RNI, 
exposure to RNI is constant over this time period. The toxicity correlates with the 
concentration of FIONO (Figure 3.11 and Figure 3.12), which is therefore a useful measure 
of the concentration of RNI in the solution.
Since amastigotes are routinely cultured at pH 5.4-5.7, the addition of sodium 
nitrite to the medium is the best way of producing RNI. The method will produce many of 
the forms of RNI that are likely to be present in the macrophage - from the small oxides of 
nitrogen (eg NO, NO+, HNO+, H^NO+, N O , HONOO) to the larger complexes with 
organic molecules (eg S-nitrosothiols and NO ligated to iron in proteins). Although RNI 
are produced in a macrophage from a completely different route (Arginine + O^  —> 
Citrulline + NO), a similar set of RNI are likely to be present in the parasitophorous 
vacuole to the species set up by acidification of RNI in proteinaceous media. This is 
because the reactions that interconvert the different RNI species are fast.
It was possible to lyse infected J774s preferentially to release viable amastigotes 
using a combination of shearing and SDS (Table 3.1), and protocol (viii) became the 
standard protocol for preparation of amastigotes from macrophages.
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J774s could produce RNI and kill amastigotes at 32°C (Figure 3.14), and both 
effects were inhibitable by l-NMMA, an arginine analogue, hinting at a role for RNI in 
macrophage killing of amastigotes. This phenomenon is investigated further in Chapter 4.
In conclusion, assays were developed for the determination of amastigote viability, 
and for RNI detection and production. A protocol for the preferential lysis of J774s was 
developed and the conditions required to stimulate J774s to kill amastigotes and produce 
RNI at 32°C were determined.
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4. Guideline experiments
8 6
4.1 Introduction
To study the effect of RNI on L. m. mexicana, it is important to consider the 
overall picture in which macrophages simultaneously produce a variety of responses 
during an infection, and to examine a possible protective response that amastigotes may 
have developed to RNI.
The effect of RNl in many systems can be affected by the presence of other 
molecules, such as proteins or oxygen radicals (27,28). These are both presept in 
activated macrophages, and in order to study the effect of RNI on L  m. mexicana 
amastigotes, the interaction of RNI with soipe of the macrophages' other defence systems 
was examined.
A study of amastigote resistance to RNI was also undertaken. It is impossible to 
correlate the concentrations of RNI that we are studying with concentrations that could be 
produced in vivo. However, if amastigotes were extremely resistant to RNI, then the toxic 
concentrations of RNI may be too high to be physiologically relevant.
Amastigote susceptibility to RNI was compared to that of proinastigotes, J774 
macrophages, Escherichia coli. Salmonella iyphimurium and Tritrichomonas foetus. 
Promastigotes were examined to see whether amastigotes had a life-cycle stage dependent 
resistance. J774s were examined to see whether the amount of RNI produced by a 
macrophage would kill amastigotes without killing the macrophage itself. E. coli was 
examined as a totally unrelated extracellular organism, while S. typhimurium was 
examined as an unrelated intracellular organism. T foetus was examined because it does 
not have a mitochondrion, which we believed may be a potential target of RNI.
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Amastigotes were either taken directly from lesions in susceptible BALB/c mice, 
or grown axenically in vitro. In both cases, they were probably not exposed to high 
concentrations of RNI. Organisms are often able to develop resistance to toxic molecules 
if they are exposed to small amounts of the toxins, so induction of an RNI resistant 
phenotype was attempted in amastigotes using exposure to low levels of RNI.
4.2 The interaction of RNI with other parasitophorous vacuole components
The interaction of RNI with three other defence components present in the 
parasitophorous vacuole (PV) was studied. The compounds selected were P- 
glucuronidase, cathepsin D and hydrogen peroxide.
4.2.1 (3-gliiciironidase and cathepsin D
To determine the concentration of PV enzymes that should be used to assess 
toxicity, a concentration curve of the toxicity of the enzymes alone towards amastigotes 
was set up. Neither of the two enzymes studied had any toxicity of their own (Figure 4.1 
and Figure 4.2), so the effect of the highest concentration of each enzyme on RNI toxicity 
was determined.
Neither enzyme had any effect on the toxicity of RNI (Figure 4.3). Therefore, RNI 
is likely to work independently of these enzymes.
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Figure 4.1: The effect of p-glucuronidase ou [^H]-thymidine uptake by amastigotes.
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[^H]-thymidine uptake by amastigotes (2 x 10  ^ml" )^ was assayed in the presence of 
different concentrations of p-glucuronidase at 32°C. Results are expressed as the mean ± 
SEM(n-4).
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Figure 4.2: The effect of cathepsin D on PH]-thymidine uptake by amastigotes.
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['^H]-thymidine uptake by amastigotes (2 x 10^  mb') was assayed in the presence of
different concentrations of cathepsin D at 32°C. Results are expressed as the mean ± SEM
(n=4).
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Figure 4.3: The effect of PV enzymes on RNI toxicity.
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[^Hj-Thymidine uptake by amastigotes (2 x 1(X’ mb') was assayed in the presence of 
sodium nitrite and either 1 mg ml ' p-glucuronidase, or 0.5 U mb' Cathepsin D, or 1 mg 
mb' BSA (as a negative control), or medium alone at 32°C, Results are expressed as the 
mean ± SEM (n=4).
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4.2.2 Hydrogen peroxide
Hydrogen peroxide is itself toxic to amastigotes in the concentration range 0.0001 
to 0.1 % (Figure 4.4).
To determine how RNI and hydrogen peroxide interact, an isobologram was 
plotted (Figure 4.5). An isobologram plots the 50% inhibitory concentration (IQ^) of RNI 
at each concentration of hydrogen peroxide, and the IC50 of hydrogen peroxide at each 
concentration of RNL If the effects of the toxins are antagonistic, then at intermediary 
concentrations of hydrogen peroxide the IC50 for RNI would be raised, and vice versa. So, 
the graph would be skewed towards the dashed line. If the toxins were synergistic, the 
graph would be skewed towards the dotted line, since the IC50 at the intermediary 
concentrations would be lowered.
Since the line is straight, the effects of the two toxins are additive, suggesting that 
they act independently of one another.
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Figure 4.4: The effect of hydrogen peroxide on pH]-thyinidine uptake by
amastigotes.
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['^Hj-thymidine uptake by amastigotes (2 x 10<^ ml-*) was measured at different
concentrations of hydrogen peroxide. A control of water was used to account for the
possible effect of the water in which the hydrogen peroxide was dissolved. Results are
expressed as the mean ± SEM (n=4).
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Figure 4.5; Isobologram of the toxicity of RNI and hydrogen peroxide on 
amastigotes
Antagonistic
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[■^HJ-thymidine uptake by amastigotes (2 x 10*^  ml ') was measured at different 
concentrations of hydrogen peroxide and sodium nitrite. The IC50 at each concentration of 
toxin was plotted at each concentration of the other toxin.
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4.3 Comparative analysis of amastigote susceptibility to RNI
The toxicity of RNI to amastigotes was compared to the toxicity to promastigotes, 
J774s, and E. coli, and development of suitable assays for S. typhimurium and T. foetus 
was attempted.
Since promastigotes and J774s normally grow in very different media to 
amastigotes, the toxicity of RNI at both pH 5.5 and 6.5 was examined. It was impossible 
to compare the toxicity of RNI at pH 7.5, because that would have necessitated using 
molar concentrations of sodium nitrite, which would almost certainly have had an 
associated osmotic toxicity as well as any toxicity due to RNL
4.3.1 Comparison to promastigotes
Amastigotes were not more resistant than promastigotes, either at pH 5.5 (which is 
similar to the pH in the PV (128)) (Figure 4.6), or at pH 6.5 (which is close to the pH of 
insect cell media) (Figure 4.7). Results from all experiments done are shown, because of 
the variability between experiments.
During the experiments at pH 6.5, control amastigotes had often transformed to 
promastigotes by the end of the 24 h incubation, and at pH 5.5, the promastigotes had 
often transformed to amastigotes by the end of the incubation.
Amastigotes were not particularly resistant to RNI compared to promastigotes, 
though in some instances, promastigotes may have been more resistant than amastigotes, 
though since this was not repeatable in all experiments, it would be rash to conclude that 
this was a real difference (Figure 4.6 (b) and (c) and Figure 4.7 (a) and (b)).
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Figure 4.6: Comparison of tlie susceptibility of amastigotes and promastigotes to
RNI at pH 5.5.
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['^H]-thymidine uptake by amastigotes and promastigotes (1 x 1(X’ mb') was assayed in 
amastigote culture medium at pH 5.5 for 24 hr 32°C. Results from three separate 
experiments are shown. Results are expressed as means ± SEM (n=4).
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Figure 4.7: Comparison of the susceptibility of amastigotes and promastigotes at pH
6.5.
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pH]-thymidine uptake by amastigotes and promastigotes (1 x lO^  ml ') in amastigote 
culture medium pH 6.5 28°iC was assayed in the presence of RNL Results from 4 separate 
experiments are shown. The mean ± SEM (n=4) are shown.
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4.3.2 Comparison to J774 cells
The concentrations of RNI that were toxic were similar in both J774s and 
amastigotes at both pH 5.5 and pH 6.5 (Figure 4.8 and Figure 4.9). Amastigotes were not 
particularly resistant to RNI when compared to J774s, and any difference was not 
repeatable between experiments.
4.3.3 Comparison to E. coli, S. typhinmrlum, and T. fqetus
Neither Salmonella typhimurium. Tritrichomonas foetus nor E. coli took up [^H]- 
thymidine in amastigote pulture medium in a dose-dependent manner (Figure 4.10 and 
Figure 4.11). E. coli was the only one of these organisms that grew in amastigote culture 
medium at all, and hence was the only organism with which it was possible to make a 
reasonable comparison to L. m. mexicana amastigotes.
The comparison of the susceptibility E. coli to amastigotes needed to be done over 
a similar time scale of exposur e for each organism. E. coli viability was assessed by the 
ODgoo- The concentration of RNI that killed E. coli outright in 18 h was comparable to 
that which killed amastigotes in 24 h (Figure 4.12). The lower concentrations may only 
have seemed to have an effect on L. m. mexicana and not E. coli, because even small 
numbers of E. coli may have outgrown the top end of the assay system. Though the assay 
system was therefore inadequate to say that E. coli was more resistant than E m. mexicana 
amastigotes to RNI, Figure 4.12 suggests that L. m. mexicana were not more resistant than 
E. coli.
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Figure 4.8: Comparative susceptibility of amastigotes and J774s to RNl at pH 5.5
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Amastigotes (1 x 10  ^ml ') and J774 (2 x 10  ^ml ') were cultured in amastigote culture 
medium at pH 5.5 for 24 h at 32°C in the presence of pH]-thymidine and sodium nitrite. 
Results are expressed as the mean ± SEM (n=4), and results from three separate 
experiments are shown.
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Figure 4.9: Comparison of the susceptibility to RNI of J774s and ainastigotes at pH
6.5.
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Amastigotes (1 x ml->) and J774 (2 x 10  ^ml->) were cultured in amastigote culture 
medium pH 6.5 for 24 h at 32°C. Results from four separate experiments are shown, and 
are expressed as the mean ± SEM (n=4).
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Figure 4.10; Uptake of [^H]-thymidine by E. coli and S. typhimurium.
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E. coli and S. typhimurium were cultured for 24 h in amastigote culture medium pH 5.5 at 
in the presence of [^H]-thymidine. Results are expressed as the mean ± SEM (n=4).
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Figure 4.11: Uptake of [^H]-thymidine by Tritrichomonas foetus
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T. foetus were cultured in amastigote culture medium at 32*C for 24 h in the presence of 
[^H]-thymidine. Results are expressed as the mean ± SEM (n=4).
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Figure 4.12: Comparison of the susceptibility of jE. coli and L. m. mexicana 
amastigotes to RNI.
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Amastigotes (1 x 10^  ml ') and E. coli (OD^ oo = 0.01 ) were cultured in amastigote culture 
medium pH 6.5 for 24 h at 33°C. Amastigote proliferation was measured by 
thymidine incorporation (mean ± SEM), and E. coli proliferation by the
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4.4 I he effect of low levels of RNI on L, m, mexicana ainastigotes.
\^hen Leishmania amastigotes first invade macrophages they encounter a small 
amount of RNI produced by one of the constitutive isoforms of nitric oxide synthase 
(eNOS or nNOS), before being exposed to higher concentrations produced by the 
cytokine-inducible isoform (iNOS).
To see whether these initial small doses of RNI induced resistance to a later larger 
dose of RNI, L. m. mexicana amastigotes were exposed to RNI for up to three days, before 
susceptibility to RNI was assayed by [^H]-thymidine uptake. This should have been a long 
enough exposure to attempt to induce a phenotypic change in susceptibility - equivalent to 
five generations in the control cultures.
The low levels of RNI did not induce any resistance to a later large exposure 
(Figure 4.13). Therefore low level RNI exposure is not sufficient to induce resistance to 
RNI.
Data from the same experiments showed that low levels of RNI cause the parasites 
to incorporate up to five times more [^Hj-thymidine than cultures that had been cultured 
without RNI for two or three days (Figure 4.14). This additional uptake was not 
accompanied by a similar increase in parasite numbers (Figure 4.14), suggesting that the 
parasites may have been synthesising DNA without dividing. It is also possible that they 
were simply taking up [^H]-thymidine more efficiently compared to their rate of de novo 
pyrimidine synthesis.
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Figure 4.13: Attempt to induce amastigote resistance to RNI by prior exposure.
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Amastigotes were cultured at 2 x 10  ^ml ' for up to 68 h at 32*<2 with various 
concentrations of RNI. Each line represents the concentration of RNI to which they were 
exposed during this initial exposure. The amastigotes were then washed, and exposed to 
freshly prepared RNI at the concentrations shown on the x-axis for 24 h in the presence of 
pH]-thymidine. Results are expressed as the mean ± SEM, and are representative of two 
separate experiments.
105
Figure 4.14: Low levels of RNI cause the parasites to take up more [^Hj-thymidine 
after two days
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Data from Figure 4.13, expressing the amount of pHj-thymidine taken up by cultures that 
were exposed to RNI, washed, and then cultured for 24 h in the absence of RNI. Results 
are expressed as the mean ± SEM and are representative of two separate experiments. 
(N.D. = Not determined).
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4.5 Conclusions
RNI work independently of some of the other factors present in the PV. The 
toxicity is not affected by cathepsin D, or ^-glucuronidase (Figure 4.3), Since the toxicity 
is additive to hydrogen peroxide (Figure 4.5), any additional hydrogen peroxide or RNI 
that the macrophage could produce would not affect the toxicity of the other at 
concentrations below those at which they killed the parasite.
The other ROI species involved in the oxidative burst is the superoxide anion. This 
molecule is extremely difficult to produce in vilro, and all the methods available produce 
short bursts of superoxide. These bursts would have been made even shorter since 
amastigote culture medium is buffered with a carbonate buffer, which reacts with 
superoxide to produce carbon dioxide. An assessment of this molecule’s interaction with 
RNI would probably have required physiologically irrelevant high concentrations of 
superoxide. In addition, since superoxide is negatively charged, the anion would have 
difficulty entering the membrane enclosed PV, so any studies in vitro would probably have 
been meaningless. Therefore, it is meaningful to study the effect of RNI on L. m. 
mexicana without adding additional hydrogen peroxide or the other PV enzymes.
There was no evidence to suggest that amastigotes were particularly resistant to 
RNI when compared to E. coli, J774s or promastigotes. From an evolutionary aspect, this 
may be surprising, since RNI are probably so important in murine resistance to 
Leishmania infection.
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In some instances, amastigotes may have been more susceptible to RNI than 
promastigotes (Figure 4.7). There could have been a multitude of reasons for this, 
including the possibility that promastigotes contained RNI scavenging molecules, or that 
they affected the pH of the medium differently to amastigotes, or that promastigotes were 
larger than amastigotes, or that promastigotes were routinely cultured in pH 7.4, and may 
have retained some of the phosphate buffer during the washing process, or that the [^H]- 
thymidine uptake assay was overloaded with parasites in these experiments.
In addition, promastigotes are not normally exposed to RNI, and any resistance 
mechanisms that they might have would therefore probably have occurred serendipitously. 
Therefore the possibility that promastigotes may be more resistant to RNI than 
amastigotes was not investigated further.
Low levels of RNI alone were not capable of inducing resistance to a later 
challenge of RNI in amastigotes within three days. This exposure was not aimed at 
inducing an RNI resistant genotype in the amastigotes, only a phenotype, to see if they 
were capable of responding to these low levels of RNI. If they do respond to low levels, 
then it takes them longer than three days, which is several generations of parasites, and 
may be too late for them to fight off an immune attack.
Low levels of RNI (1-3 pM HONO) cause the parasites to take up more [^H]- 
thymidine after being washed off (Figure 4.14). The large (up to 5-fold) increases [^H]- 
thymidine uptake were not accompanied by a corresponding increase in parasite number. 
This would suggest that the parasites were taking up ['^H]-thymidine without dividing.
This [^H]-thymidine uptake could be an indication of DNA damage being repaired
by the parasite. The added incorporation could also be due to a change in the balance of
1 0 8
pyrimidine uptake compared to de novo pyrimidine biosynthesis. The issue of DNA 
damage is examined in Chapter 6.
In summary, there was no evidence to suggest that RNI interact with any of the 
other components of the macrophage defence against Leishmania, nor that amastigotes 
were particularly resistant to RNI. It was not possible to induce an RNI resistant 
phenotype using low levels of RNI alone.
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5. RNI kill Leishmania mexicana mexicana
no
5.1 Introduction
Most of the work that has suggested a role for RNI in murine resistance to 
leishmaniasis has been done using the L. major model (62,64,68,69,85,127,210). Before 
examining RNI toxicity to L. m. mexicana in vilro, it was necessary to determine whether 
this species was also susceptible to the amounts of RNI that could be produced by a 
murine macrophage.
This chapter is concerned with establishing the macroscopic nature of the toxicity 
of RNI. That is, establishing whether RNI are cytotoxic or cytostatic, whether the toxic 
mechanism is saturable, and whether the toxicity can be affected by the concentration of 
amastigotes.
Finally, the amastigotes’ ultrastructure after treatment with RNI was examined, 
bearing in mind that often ultrastructural changes are secondary to any biochemical 
effects.
5.2 Macrophage toxicity to L. m. mexicana amastigotes.
To assay murine macrophage toxicity to amastigotes, the macrophage-like cell line 
J774 was infected with L. m. mexicana amastigotes, and stimulated for 48 h with 
interferon gamma (IFNy) and lipopolysaccharide (LPS) from Salmonella enteritidis.
J774 macrophages can kill amastigotes with RNI (Figure 5.1). This toxicity is 
inhibitable by the arginine analogue l-NMMA. The inhibition can be reversed by adding 
back extra arginine.
I l l
Killing of amastigotes correlates with the inhibition of RNI production, suggesting 
that RNI can account for macrophage toxicity.
When J774s are stimulated to the extent that they kill all the invading amastigotes, 
it is only necessary to inhibit RNI production by approximately seventy to eighty percent 
in order to rescue most of the amastigotes (Figure 5,1). This means that the amount of 
RNI produced from an activated macrophage is only a few times more than it takes to kill 
the parasites and is not orders of magnitude greater.
Therefore, it is physiologically relevant to study concentrations of RNI within one 
order of magnitude of the concentrations that kill L. m. mexicana amastigotes.
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Figure 5.1: L. m. mexicana are susceptible to an arginine dependent macrophage 
killing mechanism
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J774s were infected with amastigotes (infection ratio 10:1) overnight, and stimulated with 
IFNy (500 U mf' ) and LPS (2 pg m f‘) for 48 h. RNI production was measured by the 
accumulation of nitrite in the medium using the Griess reaction. The J774s were lysed and 
amastigote viability was measured using transformation efficiency in which amastigotes 
from control macrophages were defined as 100% viable.
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5.3 The kinetics of RNI toxicity in vitro*
5.3.1 Concentration curve of RNI toxicity
Experiments in Chapter 3 revealed the concentration of RNI that inhibited 
thymidine incorporation. However, RNI have been variously described as cytotoxic 
(133,134) or cytostatic (135) to different organisms. [^H]-thymidine uptake is probably a 
measure of DNA synthesis, so it may be a measure of cytostasis rather than cytotoxicity.
A more accurate measure of the toxic concentrations of RNI is shown in Figure 
5.2. The shape of the graph in Figure 5.2 indicates that even at concentrations of RNI 
below those that are toxic, an increase in RNI concentration will lead to fewer viable 
amastigotes. Therefore the more RNI that a macrophage can produce, the more 
amastigotes it will kill.
Amastigotes treated with RNI disintegrate - note the loss of amastigotes before 
transformation in Figure 5.2. It was possible, however, to see “ghosts” of amastigotes that 
looked like they had lost their internal organelles, and were translucent, yet retained the 
external shape of amastigotes.
The loss of amastigotes before transformation that was seen in Figure 5.2 was not 
due to a slight instability in the structure that led to parasite disintegration during the 
washing and fixing process. Ghosts of amastigotes could be seen even before the 
amastigotes had been washed, indicating that the collapse of the structure was due not to 
shearing forces caused by the centrifugation, but to the amastigotes disintegrating on their 
own.
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There is no long plateau of concentrations where the parasites have stopped 
dividing, but are still viable, suggesting that for axenically grown amastigotes, RNI are 
best described as cytotoxic rather than cytostatic in a 24 h exposure.
[^H]-thymidine uptake is also not inhibited long before the parasites die, 
suggesting that it is a reasonable viability assay for RNI toxicity.
5.3-2 Time course of RNI toxicity
RNI are produced from J774s over a period of several hours (54, Feng G. J. 
personal communication). The cells usually start producing RNI approximately six hours 
after stimulation with IFNy and LPS, with peak production at approximately 16 h, then 
slowing down over the next two days (Feng G.J., pemonal communication).
The rate at which RNI kill amastigotes depends on the amount of RNI present. 
The amount of RNI needed to kill amastigotes in 24 h is in the order of magnitude of 20 
pM HONO (Figure 5,3). We found that above that concentration, more RNI killed the 
amastigotes faster (Figure 5.4). This suggests that the target of RNI is not saturated at 
concentrations of RNI below 20 pM.
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Figure 5.2: The effect of RNI on viahiHty and [‘^ HJ-thymidine uptake by amastigotes.
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Amastigotes (2 x 10  ^ml-’) were cultured with sodium nitrite for 24 h at 32°C. During this 
period, pH]-thymidine incorporation was measured (n=4). The number of amastigotes 
was then counted (n=3), and the number of viable amastigotes was measured using the 
transformation assay (n=3). 100% viability was defined as the efficiency of transformation 
of parasites that had not been treated with RNI. The start number is the concentration of 
amastigotes before treatment with RNI expressed as a percentage of the concentration of 
amastigotes before transformation, to show how the amastigotes had grown over the 24 h 
treatment.
Results are expressed as the means ± SEM, and are representative of three separate 
experiments.
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Figure 5.3: Time course of RNI toxicity.
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Axenically grown amastigotes (2 x 10  ^ml-<) were cultured with RNI at pH 5.5 with 20 |xM 
HONO for the times shown. At each time point, a sample was removed and viability 
assayed by transformation efficiency. Results are expressed as the mean ± SEM (0=3), 
and are representative of three separate experiments.
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Figure 5.4: More RNI kill amastigotes faster.
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Amastigotes (2 x 10^  mi ') were treated with sodium nitrite at pH 5.5. At each time point, 
a sample was taken, washed, and viability assayed by transformation efficiency. The 
mean is shown, and the results are representative of three separate experiments.
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5.3.3 The effect of changing the concentration of amastigotes
It was possible that RNI were altering the metabolism of amastigotes in such a way 
that the amastigotes secreted a toxic product. The concentration of amastigotes used in 
most experiments was 1-4 x lO'' mb'. The concentration of amastigotes in a lesion is of the 
order 10'” ml '. It was necessary to determine, therefore, whether the interaction between 
parasites was important in determining RNI toxicity.
The susceptibility of different concentrations of parasites to RNI was assayed, both 
in terms of the concentration of RNI to which they were susceptible, and in terms of the 
rate at which they died.
Higher concentrations of parasites were neither susceptible to lower concentrations 
of RNI (Figure 5.5), nor did they die faster (Figure 5.6). These two figures in fact showed 
that there was very little difference between the susceptibility of high concentrations and 
low concentrations of parasites.
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Figure 5.5: Toxicity of RNI at graded concentrations of parasites.
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Amastigotes were cultured at different concentrations with sodium nitrite for 24 h, and 
viability was assayed by [^H]-thymidine uptake during that period. Results are expressed 
as the mean ± SEM (n=4), and are representative of three separate experiments.
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Figure 5.6: Time course of RNI toxicity at different concentrations of ainastigotes.
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Amastigotes were cultured in the RNI at 100 [.iM HONO, and viability was assayed at each 
time point by transformation efficiency. Results are expressed as the mean ± SEM (n=4).
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5.4 Ultrastructural changes to amastigotes on treatment with RNI.
To see if there were any ultrastructural changes visible before the parasites started 
to disintegrate, ainastigotes were treated with RM at 100 pM HONO, fixed in 
glutaraldehyde, and examined using a heavy metal stain with transmission electron 
microscopy.
No ultrastructural changes were visible within 17 min 30 s of treatment. After 2 h, 
however, there were changes visible in the nucleus, and in the mitochondrion (Figure 
5.7(c)).
In many cases, after 2 h, the nucleus had begun to disintegrate, and the chromatin 
had come away from part of the nuclear membrane (Figure 5.7(c)). Where the cln omatin 
had left the nuclear membrane, the membrane had begun to form whorls, almost half of 
the nuclei examined showed this effect (Table 5.1). Swelling of the mitochondria was 
also visible after 2 h treatment. The internal structure of the mitochondrion was less 
dense, and the internal organisation of the mitochondrion was disrupted.
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Figure 5.7: Electron microscopy of amastigotes treated with RNI.
Amas t igo tes  (2 x l ( f  ml ') were treated with RNI at 100 p M  H O N O  tor 0 min (a), 17 
min 30 s (b), or 2 h (e). At  each t ime point,  the amastigotes  were cent ri fuged and fixed 
for 20 min in glutara ldehyde,  before process ing for electron microscopy.
(a) - Four example s  of  control parasi tes
n - nucleus,  wi th dark s taining chromatin,  m - mi tochondrion,  fp - 0 age liar pocket.
1'he bars represent  0.4 [iM
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Figure 5.7 (b): Four examples of amastigotes treated with RNI for 17 min 30 s.
H .
I l l  - iiiitoclioiidrioli. t'p - Hagcllar pocket,  n - nucleus.
riie bars represent 0.4 pm.
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Figure 5.7 (c): Four examples of amastigotes treated with RNI for 2 h.
n - nucleus that has been disrupted,  w - nuclear mem brane whorls,  m - unusually swol len  
mi tochondrion.
rh e  bars represent 0.4 pm
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Table 5.1: Number of nuclei disrupted by RNI.
Time Total number of nuclei counted Total number of undisrupted nuclei
0 102 100
17 min 30 s 102 93
2 hr 100 54
Nuclei from the sections photographed in Figure 5.7(c) were counted and scored as 
“disrupted” if the nucleus contained abnormal chromatin structures, or nuclear membrane 
whorls.
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5.5 Conclusions
J774, a murine macrophage-like cell line, was able to produce enough RNI to kill 
amastigotes from L. in. mexicami. Killing of amastigotes and RNI by J774s was inhibited 
by the arginine analogue l-NMMA, and reversed by adding back arginine.
However, l-NMMA not only inhibits nitric oxide synthase, but also the cationic 
amino acid transporter systems y^  and y^L. This will affect the uptake of not only 
arginine, but lysine, and probably ornithine (51,211). Adding excess arginine would 
compete for this transport system still further, decreasing the intracellular availability of 
the other cations, but increasing the intracellular availability of arginine. Therefore, since 
the inhibition of killing could be reversed by addition of excess arginine (Figure 5.1), the 
inhibition of the uptake of the other cationic amino acids is unlikely to be the mechanism 
by which the J774s kill L. m. mexicana.
The J774 toxicity assay detected killing of parasites that had already invaded 
macrophages, and did not assay toxicity to extracellular organisms, or inhibition of 
invasion, both of which are other potential areas of macrophage interaction with L. m. 
mexicana^ but are beyond the scope of this thesis.
RNI are best described as cytotoxic rather than cytostatic to L. m. mexicana 
amastigotes. This does not mean that there are not cytostatic concentrations of RNI, as 
have been described for Achromobacter, Flavobacterium, Pseudomonas, Micrococcus, 
Escherichia, Aerobacter, Torula (212), Plasmodium falciparum (132), Mycobacterium 
leprae (47) and Toxoplasma gondii (213). A classically cytostatic molecule would, 
however, have a large range of concentrations over which it inhibits growth of the parasite
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without killing the parasite. This is not the case with RNI and L. m. mexicana amastigotes 
(Figure 5.2).
Inhibition of ['^H]-thymidine uptake by RNI takes place over the cytotoxic 
concentration range of RNI. Therefore, ['^H]-thymidine uptake is a measure of viability, 
and not simply of stasis, when used to assay RNI toxicity onL. m. mexicana amastigotes.
The time course of toxicity is several hours (Figure 5.3 and Figure 5.4), and lower 
concentrations of RNI (20 pM HONO) can sometimes take over 24 h to kill amastigotes.
The toxicity is reversible, so that if the RNI are washed off, the parasites are able to 
recover sufficiently to transform to promastigotes (Figure 5.2). This is similar to the effect 
seen in mammalian mitochondria (141,158,214) where there is an initial fast, reversible 
inhibition of energy production by the cells, followed by an irreversible damage to the 
electron transport chain of the mitochondrion.
The rate of killing contrasts with the fast rate of killing of organisms by ROI. The 
difference may be in that ROI are reported to act by damaging membranes, which are 
presumably repaired quickly, so that a low amount of ROI for a long period will not have a 
toxic effect. While the target(s) of RNI remain(s) unknown, it is impossible to speculate 
why RNI should take a long time.
More RNI kill amastigotes faster. This means that the target(s) of RNI in 
amastigotes is(are) not saturable. This also means that if there is one vital but unsaturable 
target that is affected by low concentrations, whilst there is another that is affected at 
slightly higher concentrations, it will be very difficult to pick a concentration of RNI that 
affects one without the other.
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The toxicity of RM is not affected by the concentration of amastigotes. RM are 
therefore not working by altering the metabolism of amastigotes so that they produce a 
toxic molecule that kills neighbouring cells. This is important, since the concentration of 
amastigotes in a lesion (up to 10^^  mf^) is much higher than the concentrations of 
amastigotes used here (1-4 x 10  ^mf^). Since the toxicity is not dependent upon 
amastigotes interacting with each other, the assay systems used in this thesis probably 
reflect the effect of RM on amastigotes.
No ultrastructural changes are visible in amastigotes within 17 min 30 s of initial 
exposure to RM  (Figure 5.7 (b)). The nuclei, mitochondria, surface membranes, flagellar 
pocket, and golgi apparatus are all intact.
There are ultrastructural changes in the parasites after 2 h of treatment with RM 
(Figure 5.7(c)). The nucleus and mitochondrion may both be disrupted, tliough the 
nuclear changes are more easily discernible than the changes to the mitochondrion. The 
changes to the nucleus are not similar to the condensation of chromatin seen in apoptotic 
mammalian cells (see for example (215)), they look more like the nucleus is simply 
falling apart. Up to half of the nuclei are affected in this way (Table 5.1).
The changes to the mitochondiion are characteristic of necrotic cell death. In a 
necrotic cell, the cell loses energy and is unable to maintain its osmotic balance, 
eventually lysing. Shortly before lysis, the necrotic mammalian cell will swell and both 
internal and external membranes are disrupted (188). This ultrastructural description is 
similar to what is seen in the dying amastigotes (Figure 5.7(c)).
In conclusion, the amastigotes are killed by RM produced both by a macrophage 
and axenically in vitro. The target(s) is(are) not saturable, and the ultrastiiictural changes 
are reminiscent of mammalian necrosis.
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6. The effect of RNI on glycolnositolphospholipids and DNA
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6.1 Introduction
In previous chapters, the kinetics of RNI toxicity were established. In this chapter 
the effect of RNI on two postulated targets of RNI are examined - 
glycoinositolphospholipids (GIPLs) and the deoxyribonucleic acid (DNA) ofL. m. 
mexicana amastigotes.
GIPLs are a major surface membrane component of amastigotes. The structure of 
GIPLs is shown schematically in Figure 6.1. Acidified nitrite is routinely used in the 
preparation of the sugar moiety from many different glycosyl-phosphatidylinositol 
anchored membrane components including GIPLs, and is able to cleave the sugar moiety 
from this family of molecules (183).
It was reasonable to suppose that GIPLs may therefore be a major target of RNI in 
amastigotes, especially as amastigote death was characterised by the parasites 
disintegrating.
Another possible target of RNI is the DNA. Given the disruption to the nuclear 
structure that seen in electron micrographs, and the increase in [‘^ Hj-thymidine 
incorporation seen by treating amastigotes for a long time with low levels of RNI, this was 
considered quite a likely target.
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Figure 6.1: Structure of GïPL and where it is attacked by RNI (183,246)
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The assay system (nick translation) that was used for detecting DNA damage by 
RNI was developed from a paper in which rat pancreatic islet cells were treated with the 
RNI producer sodium nitroprusside (SNP) (53). This led to DNA damage that was not 
inhibitable by inhibitors of endogenous endonucleases, suggesting that the damage was 
therefore probably not due to apoptosis. The authors concluded that islet cell DNA was an 
early target of attack by nitric oxide.
6.2 The effect ofRNl on GIPLs
GIPLs can be labelled on the sugar moiety by incubating amastigotes in glucose- 
free medium supplemented with [^H]-glucosamine. The GIPLs may then be purified from 
amastigotes by chloroformimethanoliwater extraction followed by butanobwater partition. 
If the sugar moiety is still attached to the inositol phospholipid moiety, then the label will 
partition in the butanol fraction. If the sugar moiety has detached, then the label will 
partition in the water fraction.
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The concentration of RNI in sodium acetate buffer required to remove the sugar 
moiety from GIPLs is extremely high (niM range) compared to the concentration required 
to kill amastigotes (tens of pM range) (Figure 6.2(a)),
In amastigote culture medium, it was not possible to get the concentration of RNI 
to the concentrations attainable in sodium acetate buffer (Figure 6.2(b)). However, there 
was still no change in the partitioning of the label, and the concentration was still far 
above the toxic concentration of RNI.
When GIPLs were treated with RNI in amastigote culture medium, most of the 
label partitioned with the water phase in control cultures. There are two possible reasons 
for this. Either the salts and protein in the medium may have altered the solvent properties 
of the solution enough to prevent efficient partitioning. Or there may be an enzyme that 
breaks down GIPLs in serum. Whatever the reason for the anomaly in the control culture, 
there was no change in the partitioning characteristics with increasing RNI, and the ratio of 
counts in the water phase to counts in the butanol phase never reached as high as it did in 
sodium acetate buffer at the highest concentration of RNI. This suggests that the RNI are 
still not attacking the GIPLs in culture medium.
Therefore degradation of GIPLs is unlikely to be a major factor in the toxicity of 
RNI, since GIPL degradation occurs at much higher concentrations of RNI than it takes to 
kill amastigotes.
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Figure 6,2: The effect of RNI on GIPL integrity.
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GIPLs were purified from amastigotes, and treated in either sodium acetate buffer pH 4.0 
or amastigote culture medium (pH 5.5) for 24 h at 32°C, then partitioned between water 
and butanol. Where the label partitions in the water fraction, the sugar moiety has been 
cleaved from the inositol lipid moiety (open diamonds), where the label partitions in 
butanol, the sugar moiety is still attached to the inositol lipid moiety (closed diamonds).
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6.3 DNA damage
RNI damage to DNA was assayed using nick translation. The principle behind this 
technique is shown schematically in Figure 6.3. The amastigotes were treated with RNI or
2,4-dinitrophenol (DNP) for up to 4 h. DNP was used as a control for killing amastigotes 
with a toxin that does not directly damage DNA. The DNA was then extracted and 
purified, and mixed with the Kornberg fragment of DNA polymerase and 
deoxyribonucleotides containing p^P]~a-dATP. Since the Kornberg fragment contains a 
5’-3’ exonuclease activity as well as a synthase activity, it translates single strand nicks 
along the double helix, replacing cold nucleotides with hot nucleotides (206).
Nick translation detects double strand breaks as well as single strand nicks in the 
DNA, since DNA polymerase can label the ends of both blunt-ended and overhanging 
DNA strands (206).
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Figure 6.3: Overview of the nick translation procedure.
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6.3.1 Development of the nick translation system
6.3.1.1 The published assay system
The published assay system used cold nucleotides with biotinylated dUTP in place ■ &
of dTTP (53), and detected the incorporation of the labelled nucleotide using the 
peroxidase reaction with diamiiiuobenzidine as enzyme substrate. In order to allow 
quantification of the damage, I used [®P]-a-dATP instead of biotinylated dUTP, and 
detected incorporation in some experiments by TCA precipitation and in others by agarose 
gel DNA electrophoresis followed by transferring the DNA to a nylon membrane for 
autoradiography.
Using amastigote DNA, approximately 50% of the radiolabel was incorporated 
into the DNA within 2 h (Figure 6.4). There was no change in the amount of label 
incorporated on addition of either RNI or DNP.
However, the lack of difference may simply have reflected the fact that so much of 
the radiolabel had been incorporated into the control DNA even without extra damage.
The fact that this occurs in amastigote DNA, and not in the published control mammalian 
DNA, may have been due to the smaller fragment size of amastigote DNA compared to 
mammalian DNA. This would have meant that the end-labelling of the DNA strands may 
have used up all the dATP.
The published assay was therefore not suitable for studying amastigote DNA, since 
it was limited by the availability of dATP. So it became necessary to develop a system 
where the amount of radiolabel incorporated was dependent upon the number of nicks in 
the DNA, and not upon the concentration of dATP or any of the other nucleotides.
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Figure 6.4: Nick translation of amastigote DNA.
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Amastigotes (4 x 10'^  ml"') were treated with RNI or DNP for up to 4 h at 32"C. At each 
time point, a sample was taken, DNA purified, and nick translated in a reaction containing 
a final 1.7 nM dATP for 120 min at room temperature. Label incorporation was detected 
by precipitating the DNA with TCA, and filtering the precipitate.
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6.3.1.2 Increasing the cold dATP concentration.
Since most of the ['^^P]-a-cIATP was incorporated into control DNA, the rate of 
incorporation of [^^P]-a-dATP into control DNA was assayed in the presence of an 
increased concentration of cold dATP (final [dATP] = 3.5 pM as compared to 1.7 nM used 
previously).
Even with 3.5 pM dATP, there was only an increase in label up to 15 min (Figure 
6.5), indicating that the reaction was still limited by the availability of dATP.
The concentration of dATP had to be increased to 80 pM to get a time course of 
incorporation which would be long enough to enable measurement of up to sixteen 
samples with reasonable reliability (Figure 6.6). The concentration of the other 
nucleotides was also increased to 80 pM, so that they would not limit the rate of the 
reaction either.
The addition of DNase 1 to the reaction demonstrated that more radiolabel would 
be incorporated if there were more nicks in the DNA (Figure 6.6). In the presence of Mg^^  
ions, DNase 1 creates single strand nicks rather than double strand breaks in DNA (206), 
which is why the buffer contains MgClg.
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Figure 6.5: Time course of the nick translation reaction with 3.5 g,M dATP
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Amastigote DNA was incubated in the nick translation reaction mixture containing 3,5 f.iM 
dATP at RT for up to 120 min. At each time point, a 2 pi sample was removed, stopped 
with 0.2 M EDTA, and TCA precipitated to determine the amount of ['^^PJ-a-dATP 
incorporated into the DNA.
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Figure 6 .6 :  Nick translation of amastigote DNA with 8 0  jliM  dATP,
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Amastigote DNA was treated with the nick translation mixture containing 80 |iM dATP, 
dCTF, dTTP and dGTP, and 90 jjiU fxl ’ DNase 1 at 15°C. At each time point, 20 pi of the 
reaction was stopped in 580 pi 0.2 M EDTA, and the percentage of [-’^ P]-a-dATP that was 
taken up by the DNA was assayed by TCA precipitation.
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6.3.1.3 Construction of a standard curve with DNase I
Having developed the assay system, it was possible to show that the more the DNA 
was nicked, the more label was incorporated into it (Figure 6.7). However, there was a 
bigger difference between the amount of labelling with DNase 1 and without DNase 1 
after a two hour incubation than after a shorter incubation(Figure 6.7(b)). This suggests 
that the incubation period should be 120 min to get the maximum difference between 
labelled and unlabelled DNA.
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Figure 6.7: The effect of DNase 1 on DNA labelling in the nick translation reaction.
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Amastigote DNA was treated with nick translation reaction mixture containing 56 [xM 
dATP, dCTP, dGTP and dTTP, and various concentrations of DNase 1. At each time 
point, 20 jil reaction was removed, and stopped with 580 \x\ 0.2 M EDTA, and the label 
incorporated was detected by TCA precipitation. Results are expressed both as the 
variation in labelling with time (a) and with the concentration of DNase 1 (b), and are 
representative of three separate experiments.
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6.3.1.4 Nicking control amastigote DNA before translation.
The previous experiments showed that more label gets incorporated into the DNA 
if the DNase 1 is included in the translation mixture with the DNA polymerase. However, 
it was important to be able to detect damage to DNA that had already been nicked. So, to 
determine that the technique could do this, a standard curve of DNase 1 nicked DNA was 
constructed.
The cuive in Figure 6.8 was constructed by adding the DNase 1 to the DNA, and 
incubating at 37®C for 2 h. The translation reaction was then added to the nicking 
mixture, and incubated at 15°C. The dilution and the drop in temperature for the second 
incubation slow the rate of nicking down 160-fold (206). This means that over 99% of the 
nicking took place in the first incubation.
The modified technique detected damage to amastigote DNA below approximately 
1 mU pf^ DNase 1. Above this concentration, the amount of damage could sometimes be 
so much that the assay incorporated less [^¥]-a-dATP with increasing DNase 1 (Figure 
6.9).
Additional damage leading to less label in the TCA precipitable fraction could be 
because smaller fragments did not precipitate as efficiently, or because the DNA 
polymerase could not work efficiently on badly damaged DNA.
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Figure 6.8: DNase 1 standard curve with the amastigote DNA being nicked before 
the translation reaction.
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Amastigote DNA was treated with DNase 1 for 2 h at 37°C. The translation reaction 
mixture containing 56 [iM of all deoxyribonucleotides (final concentration) was then 
added, and incubated for a further 2 h at 15°C. The reaction was stopped with 580 pi 0.2 
M EDTA, and [‘^ ^P]-a-dATP incorporation was assayed by TCA precipitation.
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Figure 6.9: Standard curve of DNase 1.
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Amastigote DNA was treated with DNase 1 for 2 h at 37°C. The translation reaction 
mixture containing 56 pM of all deoxyribonucleotides (final concentration) was then 
added, and incubated for a further 2 h at 15°C. The reaction was stopped with 580 pi 0.2 
M EDTA, and pP]-a-dATP incorporation was assayed by TCA precipitation. Note that 
the concentration range on the x-axis is higher than that in Figure 6.8.
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6.4 Detection of damage to amastigote DNA caused by RNI.
6.4.1 The effect of RNI on DNA in intact amastigotes
Using the modified nick translation assay, damage caused by RNI to live 
amastigote DNA was assessed. There was little ['^^Pj-a-dATP incorporated into any of the 
DNA prepared from amastigotes treated with RNI or DNP (Figure 6.10). This either 
suggests that there was no detectable damage to the DNA, or that the damage was so great 
that it was above the level detectable with TCA precipitation of the nick translation 
reaction (Figure 6.9).
The low amount of label probably represents little damage since running the 
standard curve on an agarose gel showed that additional label could be detected in the 
chromosomal DNA up until the point that smearing of the DNA appeared on the 
autoradiograph (Figure 6.11 (c)).
There was, however, a caveat. On running the sample DNA on a gel stained with 
ethidium bromide, it was discovered that different amounts of DNA had been loaded into 
each reaction (Figure 6.11(b)).
The reason for the variation was probably that measurement of the concentration of 
DNA using OD^g/OD^go is affected by even small concentrations of impurities in the 
preparation, rather than a pipetting error. The evidence for this was twofold. Firstly, the 
GDjco/ODjgo had been measured in triplicate, and the variation in readings was not large. 
Secondly, the amount of DNA that had been loaded into the standard curve was reasonably 
similar in each lane (Figure 6.11(a)).
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The amount of label incorporated into each tube in Figure 6.10 could therefore be 
explained by the different amounts of DNA. Despite this, the amount of label did not 
consistently change with increasing amounts of RNI (Figure 6.11(d)).
Therefore the concentration of DNA was normalised between samples with 
ethidium bromide fluorescence, by modifying a technique described in Molecular Cloning 
- A Laboratory Manual (206) to make the technique quantitative.
Using amastigote DNA, whose concentration had been calculated using 
OD.gn/OD^ go, we were able to construct a standard curve of DNA in PBS containing 2 pg 
ml"' ethidium bromide (Figure 6.12). Reading the concentration of DNA from the 
different samples using this standard curve, it was possible to get slightly more even 
concentrations of DNA loaded into each sample of the nick translation reaction (Figure 
6.13(a)).
It was still not possible to detect any damage to the DNA with different treatments 
of RNI or DNP (Figure 6.13).
148
Figure 6.10; Nick translation of amastigote DNA using the modified nick translation
assay.
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Amastigotes were treated with RNI or DNP for the times shown, DNA was then extracted, 
and nick translated using the modified nick translation reaction (56 pM dNTP), The 
amount of radiolabel incorporated into the DNA was assayed by TCA precipitation.
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Figure 6.11: DNase 1 standard curve and nick translation of amastigote
DNA
( a)  1 2  3 4 5 6 ( b)  7 8 9 10 11 12
(d) 7 8
A standard curve was constructed by treating control amastigote DNA with increasing 
concentrations of DNase I (3-fold serial dilutions from 0.27 mU jil ') (a) and (c). 
Amastigotes (4 x l(f ml*' ) were treated with 100 |iM RNI or 200 |iM DNP for up to 4 h 
(7 - control. 8 - RNI 1 h, 9 - DNP 1 h, 10 - RNI 2 h, 11 - DNP 2 h, 12 - DNP 4 h) (b) 
and (d). DNA was purified, and damage was detected by nick translation followed by 
separation on a 0.8% agarose gel. The gels were stained with ethidium bromide (a) and 
(b), and then the DNA transferred to a nylon filter for autoradiography (c) and (d).
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Figure 6.12: Standard curve of ethidium bromide fluorescence.
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Serial dilutions of amastigote DNA were placed in 50 pi 2 pg ml ' ethidium bromide in 
PBS in a 96 well plate. The excitation wavelength was 254 nm, and the emission 
wavelength was 605 nm.
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Figure 6.13: The effect of RNI on nick translation of amastigote DNA.
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Amastigotes were treated with RNI ( 100 pM HONO) or DNP (200 pM) for up to 4 h at 
32°C. The DNA was then extracted, nomialised using ethidium bromide measurement, 
and treated with the nick translation mixture containing 56 pM dNTP. The labelled DNA 
was run on a 0.8% agarose gel stained with ethidium bromide and photographed (a). The 
DNA was transferred to a nylon membrane by capillary action (b), for autoradiography. 
The moleculai* weight markers were labelled with the nick translation mixture that end- 
labels linear DNA.
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6.4.2 The direct effect of RNI on DNA in vitro.
Since it had not been able to detect any damage to the DNA in amastigotes at 
concentrations of RNI that killed amastigotes, the concentrations of RNI at which it was 
possible to detect damage to DNA using nick translation were examined.
DNA was prepared from amastigotes, and incubated in sodium acetate buffer pH 
4.0 for 4 h at 32°C. The incubation mixture was neutralised with 10 M sodium hydroxide, 
and labelled with the nick translation mixture. Damage was assayed by running the DNA 
on a 0.8 % agarose gel, photographing it, then transferring it to a nylon filter for 
autoradiography.
RNI did not cause damage directly to DNA that was detectable with nick 
translation (Figure 6.14). RNI did, however, damage the DNA in a way that makes the 
DNA stay in the well at high concentrations of RNI (82.5 mM HONO). At this 
concentration, a yellow residue was visible in the reaction mixture, confirming that the 
DNA and RNI had reacted.
This was consistent with a rare, though not unprecedented, type of damage in 
which the diazotisation reaction leads to cross-linking of DNA strands (216).
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Figure 6.14: The direct effect of RNI on amastigote DNA.
(a) [HONO] *iM (h ) [HONO] ihM
0 «■ 1:10 d i lu t io n s^  82.5 0 1:10 dilutions^ 82.5
Amastigote DNA was treated with sodium nitrite in sodium acetate buffer pH 4.0 for 4 h. It 
was then neutralised, labelled with the nick translation mixture, and run on a 0.8% agarose 
gel. It was then photographed (a), and transferred to a nylon filter for autoradiography (b).
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6.4.3 The effect of RNI on DNA in amastigote culture medium.
Since it was impossible to detect any damage to the DNA caused by RNI in 
sodium acetate buffer, damage to DNA caused by RNI in amastigote culture medium was 
assessed.
Amastigote DNA was incubated in serial dilutions of sodium nitrite in amastigote 
culture medium for 4 h (Figure 6.15). The concentration of RNI obtainable was not as 
high as those obtainable in sodium acetate buffer.
It was impossible to assay damage to DNA in this system since there was a DNase 
activity in amastigote culture medium that degraded amastigote DNA at low 
concentrations of RNI. However, high concentrations of RNI inhibited this DNase activity 
(Figure 6.15).
The DNase activity in amastigote culture medium was in the serum fraction of the 
medium (Figure 6.16)
155
Figure 6.15: The effect of RNI on degradation of DNA in amastigote culture 
medium.
[HONO]
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Amastigote DNA was incubated in amastigote culture medium containing sodium nitrite for 4 
h at 32°C. Control DNA was in TE buffer. The reaction was then neutralised and DNA 
separated run on a 0.8 % agarose gel containing ethidium bromide.
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Figure 6.16: Degradation of DNA by serum in amastigote culture medium
1 2 3
Amastigote D N A was incubated in amastigote culture m edium  pH 5.5 containing 20% FCS 
( 1 ), or no FCS (2), or in T E  buffer (3) for 4  h. T he D N A  was run on a 0 .8%  agarose gel 
stained with ethidium  bromide.
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6.5 Conclusions
Neither DNA nor GIPLs are likely to be major early targets of RNI attack on L, m. 
mexicana amastigotes. Both components are susceptible to large concentrations of RNI, 
but it was not possible to detect any damage to either at concentrations of RNI that kill 
amastigotes.
Damage to both DNA and GIPLs involves a diazotisation reaction that can either 
continue by removing an amine group, or in some cases in DNA, cross-link the double 
helix (216). It may not be surprising that diazotisation reactions are not important in vivo 
since the reaction rate for diazotisation is up to 10'’ times slower than the reaction of RNI 
with sulphydryl groups (31), which in turn react slower than the iron-sulphur centres of 
many enzymes.
On the other hand, RNI have been used as mutagens on living cells (171,175), 
suggesting that a diazotisation reaction with DNA may be significant at levels which are 
not completely toxic. However, it is much more common to find experimenters using RNI 
mutagenesis on DNA that has been purified from bacteria, and then added back to the 
bacteria or on viruses (171).
The published assay for mammalian DNA labels amastigote DNA extremely 
efficiently. It proved necessary to increase the concentration of competing cold dATP 
approximately 10' fold to stop dATP limiting the amount of incorporation into control 
DNA. The reason for this may be that amastigote DNA is in much smaller fragments than 
mammalian DNA, or that amastigote DNA already has many single strand nicks in it. On 
the basis of these results, it is only possible to speculate as to which is more likely.
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It was necessary to develop the nick translation system to detect damage to 
amastigote DNA. There was a bigger difference between nicked DNA and undamaged 
DNA if the translation reaction was allowed to proceed for up to 2 h. This suggests that 
there were so many sites for binding of DNA polymerase in control DNA, that adding 
extra sites did not increase the amount of label incorporation until those initial sites had 
been repaired. In this case, the'concentration of DNA polymerase would have limited the 
rate of the reaction, but the end-point would have been determined by the number of nicks.
The assay as developed detected damage caused by DNase 1. The more damage, 
the more label was taken up. However if too high a concentration of DNase 1 was used, 
less label was taken up. With autoradiography, however, it was apparent that more label 
was incorporated into chromosomal DNA until the point at which it began to smear on the 
gel. It is therefore likely that the damage to amastigote DNA was not above the level 
detectable with nick translation, and that any damage caused by RNI was too small to be 
detected.
RNI inhibit the DNase activity in serum. In many inflammatory autoimmune 
diseases, RNI are produced at the site of inflammation, and often systemic a-DNA 
antibodies can be detected. The concentrations of RNI that totally inhibit DNase in Figure 
6.15 are much higher than the concentrations required to kill amastigotes and J774 cells, 
so are likely to be much higher than those found physiologically. Despite this, lower 
concentrations of RNI may slow down the rate of degradation of DNA in serum and our 
assay would not have detected such small changes in enzyme kinetics. In this case, the 
presence of RNI in an inflammatory lesion may prolong the half life of DNA released 
from necrotic cells, thereby contributing to the formation of a-DNA antibodies.
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In conclusion, DNA and GIPLs are unlikely to be major early direct targets of RNI 
attack on amastigotes.
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7. The effect of RNI on amastigote mitochondrial function.
1 6 1
7.1 Introduction
In E. coli and many mammalian systems, some of the targets of RNI are the iron- 
sulphur containing enzymes of the mitochondrial electron transport chain (26). To assess 
whether the mitochondrion in amastigotes was affected by RNI, and whether this could 
account for the toxicity of RNI, several measures of mitochondrial function were assayed - 
oxygen uptake, rhodamine 123 (Rhl23) uptake, and the concentration of ATP.
Oxygen uptake is a measure of the ability of the electron transport chain to carry 
electrons, since oxygen reduction is the final step in this pathway. If the electron transport 
chain is disrupted at any point, oxygen uptake will be affected.
Rhl23 provides a measure of the energy-production capacity of the mitochondrion. 
It is a positively charged fluorescent dye whose uptake is dependent on the membrane 
potential across the mitochondrial membrane (217). The larger the membrane potential, 
the more Rhl23 is taken up.
Many organisms, as phylogenetically diverse as archaebacteria and mammalian 
cells have a pump that can remove Rhl23 from the mitochondrion (in the case of 
mammalian cells) or the bacterium (218). This pump can be inhibited by some of the 
mitochondrial uncouplers (e.g. FCCP), so that whereas some mitochondrial inhibitors 
decrease Rhl23 uptake, others may increase it. Therefore, a positive control that inhibits 
Rhl23 uptake was chosen - 2,4-dinitrophenol (DNP).
Another consideration when using Rhl23 is that at high concentrations it auto- 
quenches. This means that in some instances, the more Rhl23 that is taken up by a 
mitochondrion, the less fluorescent light will be emitted (219).' At lower concentrations of 
Rhl23, the more dye that is taken up, the more fluorescent light will be emitted.
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The concentration of ATP is a measure of how effectively the mitochondrion 
actually provides energy to the amastigote cytoplasm. Many researchers measure the 
concentration of ADP and AMP as well, and express this energy availability in terms of 
the “Adenylate Energy Charge” (AEG) (204,220):
= [ATT? *
This was not, however, an appropriate measure for my purposes. The AEG would 
remain unchanged if the plasma membrane was damaged by RNI, allowing nucleotides to 
leak out of the amastigotes. Indeed pH]-adenine release is often used in mammalian cells 
as a measure of cellular viability. The concentration of ATP alone therefore provided a 
better assessment of how much energy was available for reactions that require ATP than 
the AEG.
Initially, it was important to assess whether the axenically grown amastigotes were 
susceptible to any sort of mitochondrial toxin, and if so, to what concentrations they were 
susceptible.
7.2 Axenically cultured amastigotes are susceptible to mitochondrial toxins.
[■^H]-thymidine uptake by amastigotes was affected by all three mitochondrial 
toxins tested- sodium azide (Figure 7.1), carbonylcyanide P- 
trifluoromethoxyphenylhydrazone (FGGP) (Figure 7.2) and 2,4-dinitrophenol (DNP) 
(Figure 7.3). Sodium azide inhibits the electron transport chain, while FGGP and DNP are 
uncouplers.
pH]-thymidine uptake by amastigotes is therefore dependent on energy production 
by their mitochondrion.
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Figure 7.1: The effect of sodium azide on [^H]-thymidine uptake by amastigotes.
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[-'H]~thymidine uptake by amastigotes (1 x 10<5 mb') was assayed in the presence of 
sodium azide for 24 h at 32°C. Results are expressed as the mean ± SEM (n-4).
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Figure 7.2: The effect of FCCP on [^H]-thymidlne uptake by amastigotes.
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pH]“thymidlne uptake by amastigotes (1 x W  ml-’) was assayed in the presence of FCCP 
for 24 h at 32°C. Results are expressed as the mean ± SEM (n=4).
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Figure 7.3: The effect of DNP on [^H]-thymidine uptake by amastigotes.
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[‘''H]-thymidine uptake by amastigotes (1 x 10  ^mb’) was assayed in the presence of FCCP 
for 24 h at 32°C. Results are expressed as the mean ± SEM (n=4).
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7.3 RNI inhibition of mitochondriai function.
7.3.1 Oxygen consumption
Before the acidified nitrite system for assessment of RNI toxicity was developed, 
S-nitroso-N-acetyl penicillamine (SNAP) was used to produce RNI. During this period, 
mitochondrial function was assessed by the inhibition of oxygen uptake by amastigotes.
In all experiments, fully aerated amastigote culture medium was defined as 100 % 
saturation, and a dilute solution of sodium sulphite defined as 0 % saturation. Without a 
detailed analysis of the solubility of oxygen in amastigote culture medium, it was 
impossible to convert these figures to molar quantities.
Even in sterile amastigote culture medium, there was a baseline consumption of 
oxygen of approximately 0.24 % min ' (Figure 7.4). As the concentration of amastigotes 
increased from 10*^  to 10^  ml'% more amastigotes consumed oxygen more quickly. This 
covered the concentration range that we used for all experiments.
The rate of oxygen consumption by amastigotes was inhibited by concentrations of 
SNAP up to 1 mM (Figure 7.5). The oxygen consumed by SNAP concentrations above 1 
mM obscured any effect on amastigote oxygen consumption. This effect was probably 
due to the reaction of nitric oxide with molecular oxygen in solution to produce nitrite and 
nitrate anions.
A half-hour exposure of amastigotes to 1 mM SNAP was not normally completely 
toxic (Figure 3.10). Therefore amastigotes were able to recover from this level of 
inhibition of oxygen consumption for this time period.
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Figure 7.4: Oxygen consumption by amastigotes.
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Oxygen uptake by different concentrations of amastigotes was measured in amastigote 
culture medium.
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Figure 7.5: Inhibition of amastigote oxygen consumption by SNAP.
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Oxygen uptake by amastigotes (2 x 10^  ml ') in amastigote culture medium was measured 
in the presence of SNAP. Results are representative of three separate experiments.
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7.3.2 The mitochondrial membrane potential
To assess the effect of RNI on the mitochondrial membrane potential, uptake of 
Rhl23 was measured using a Fluorescence Activated Cell Sorter (FACS). As Rhl23 
accumulates in the mitochondrion, it initially leads to more fluorescence per parasite, but 
at higher concentrations, it auto-quenches, and more Rhl23 uptake can lead to less 
fluorescence.
For safety considerations, it would have been preferable to fix the amastigotes 
before using the FACS. Rhl23 in some cells can be retained for up to 24 h after fixation 
(217), but it is not chemically attachable to any mitochondrial components, so in most 
systems it leaches out quickly. It was therefore necessary to assess whether the dye was 
fixable in amastigotes.
7.3.2.1 Development of the assay:
7.3.2.1.1 Assessment of the effect of fixation
Amastigotes labelled with Rhl23 before running through the FACS lose a 
significant amount of the label by 25 min compared to live amastigotes (Figure 7.6). After 
2Vi hours, most of the label has leached out of amastigotes. It is therefore not sensible to 
fix amastigotes after labelling with Rhl23 before FACS analysis.
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Figure 7.6: The effect of fixation on Rhl23 retention by amastigotes.
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Amastigotes (2 x ml ') were incubated in 13 pM Rhl23 for 15 min at 32'"C. They 
were then spun at 1600g 5 min RT, and resuspended in FACSFlow with or without 1% 
paraformaldehyde. Clumps of amastigotes were broken up by pushing the suspension 
three times through a 26G% needle, and 2000 particles were collected on the FACS. 
Results are expressed as the mean ± SEM.
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7.3.2.1.2 Time course of Rhl23 uptake by axenic amastigotes.
13 jxM Rhl23 is taken up by amastigotes over 21 min. A reading above 
background was obtainable after six minutes, which means we were able to assess 
mitochondrial function over a six minute period (Figure 7.7).
The fluorescence increase was not linear over the 20 min, presumably because of 
auto-quenching by Rhl23, and possibly because the postulated efflux pump may have 
removed the Rhl23 more efficiently at higher concentrations.
A six minute uptake of Rhl23 is in the range in which more Rhl23 uptake would 
lead to more fluorescence, while an inhibition of Rhl23 uptake would lead to less 
fluorescence.
7.3.2.2 Concentration curve of the effect of DNP
Below 100 pM, DNP inhibited Rhl23 uptake. Between 100 pM and 1 mM DNP, 
however, Rhl23 uptake increased (Figure 7.8). 200 pM DNP was therefore used as a 
positive control for inhibition of Rhl23 uptake.
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Figure 7.7: Uptake of Rlil23 over time.
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Amastigotes (2 x 10*’ ml ’) were cultured in 13 |iM Rhl23 with or without 2 niM DNP. At 
each time point, 20 pi of the sample was placed in 1 ml FACSFlow, and 2000 particles 
were collected on the FACS.
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Figure 7.8: Concentration curve of the effect of DNP on Rhl23 uptake.
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Amastigotes (2 x 10^  ml ') were incubated for 6 min in DNP containing 13 pM Rhl23. A 
sample of 20 pi was then mixed with 980 pi FACSFlow, and collected on the FACS. 
Results are expressed as the mean ± SEM, and are representative of three separate 
experiments.
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7.3.2.3 The effect of RNI on Rhl23 uptake.
Having determined the conditions that would enable an assessment of the effect of 
RNI on Rhl23 uptake, the time course and the concentration at which RNI had their effect 
on Rhl23 uptake by L, m. mexicana amastigotes was investigated.
7.3.2.3.1 Time course of inhibition
RNI at 100 pM HONO inhibit the uptake of Rhl23 very quickly (Figure 7.9). The 
first time point shown represents an exposure of six minutes to RNI, and already uptake is 
inhibited to the same extent as 200 pM DNP. For the rest of the exposure to RNI (up to
7.1 h), the membrane potential remains low, indicating that the amastigotes do not find a 
way of combating the inhibition.
The mean fluorescence of control amastigotes increases with the amount of time 
that they are cultured before being exposed to Rhl23 (Figure 7.9). This is probably due to 
the amastigotes clumping during the culture. The clumps of amastigotes were only broken 
up before the initial culture, and not just before they were exposed to Rhl 23.
This hypothesis was tested by dividing the forward and side scatter region which 
contains amastigotes into four different regions of increasing size (Figure 7.10), and 
measuring the mean fluorescence per particle in each region (Figure 7.11(a)). Except in 
the case of the largest region, the mean fluorescence per particle in each region hardly 
changed. The mean fluorescence of the largest particle size would be expected to increase 
as the mean particle size increased.
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The number of particles in each region, however, did change over the time course 
of the experiment (Figure 7.11(b)). On average, the particles increased in size. 
Amastigotes did not get bigger if observed under a microscope, but they were clumping. 
This suggested that the increase in particle size was probably due to clumping of 
amastigotes that remained the same size.
RNI inhibited the R hl23 uptake by all particle sizes (Figure 7.12), and so was not 
preventing the increase in fluorescence simply by stopping the amastigotes clumping.
RNI therefore inhibits R hl23 uptake by axenic amastigotes quickly. The fast rate 
of inhibition contrasts markedly with the time course of killing of several hours seen in 
Figure 7.21 and in Figure 5.4.
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Figure 7.9: Time course of the effect of RNI on Rhl23 uptake.
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Amastigotes (2 x 10^  ml"') were cultured in medium containing either RNI (100 jiM 
HONO), 200 |iM DNP, or neither. At each time point, a sample was mixed with Rhl 23 
(final concentration 13 pM) also containing RNI, DNP or neither, and incubated for 6 min 
32°C. 20 pi of this mixture was mixed with FACSFlow, and 2000 particles were collected 
on the FACS. Results are expressed as the mean ± SEM and are representative of three 
separate experiments.
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Figure 7.10: Arbitrary division of particles into four sizes.
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A clot plot showing the forward and side scatter data from control amastigotes after a 6 
min incubation in R hl23 from Figure 7.9. Forward scatter increases with increasing 
particle size, while side scatter increases with increasing refractive index of each particle. 
The four regions were chosen arbitrarily, and were of increasing size (R1 - Smallest, R2 - 
Small, R3 - Large, R4 - Largest).
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Figure 7.11: Analysis of the time course of R hl23 uptake in terms of the different
sizes of particles.
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Data from control treatment in Figure 7.9 reanalysed taking into account the four region 
sizes defined in Figure 7.10.
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Figure 7.12; The effect of RNI on R h l23 uptake by amastigotes.
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Data from RNI treatment in Figure 7.9 reanalysed taking into account the four region sizes 
defined in Figure 7.10.
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7.3.2.3.2 Concentration curve of RNI inhibition of R hl23 uptake.
The concentration of RNI required to inhibit Rhl23 uptake was similar to the 
concentration required to inhibit [^H]-thymidine uptake by amastigotes (Figure 7.13), 
When compared to the concentrations required to deglycosylate GIPLs or to damage DNA 
(Chapter 6), these concentrations are very similar to the toxic concentrations of RNI.
The inhibition of R hl23 uptake by DNP is also very similar to the concentration 
required for DNP to inhibit [’^ Hj-thymidine uptake (Figure 7.14).This suggests that the 
inhibition of the mitochondrial membrane potential alone can account for the toxicity of 
RNI.
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Figure 7.13: Comparison of the effect of RNI on R hl23 and pH]-thyinidine uptake.
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[■^H]-thymidine uptake by amastigotes (2 x 10® ml ') was assayed over 24 h in the presence 
of RNI, and Rhl23 (13 pM) uptake was assayed over 6 min. Results are expressed as the 
mean ± SEM, and are representative of two separate experiments.
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Figure 7.14: The effect of DNP on Rhl23 and pH]-thymidine uptake.
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[‘^ H]-thymidine uptake by amastigotes (2 x 10^ ’ mi"') was assayed over 24 h in the presence 
of DNP, and Rhl23 (13 pM) uptake was assayed over 6 min. Results are expressed as the 
mean ± SEM, and are representative of two separate experiments.
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7.4 The effect of RNI on the concentration of ATP.
L. m. mexicana amastigotes normally live in a subcutaneous lesion that has very 
little vascularisation. This might suggest that they normally live in very low oxygen 
tensions, and may be able to survive on ATP produced anaerobically. To test whether 
RNI attack does actually lead to a decrease in the amount of energy cytoplasmically 
available, we measured the concentration of ATP using luminescence from firefly 
luciferase.
Firefly luciferase cannot use dATP, NADH or NADPH as substrates, so the 
measurements here represent changes in the concentration of ATP alone.
Neutralised TCA lysates were prepared by mixing 100 pi of the sample with 900 
pi of 5.56 % TCA, spinning at 12 OOOg for 20 min at 4°C, and neutralising 500 pi of the 
supernatant with 51-55 pi of 3 M KOH/0.4 M Tris/0.3 M KCl.
7.4.1 Development of the assay system
The amount of light emitted from luciferase in the presence of 10 ''' M ATP was 
detectable (Table 7.1). However, the luminometer reading decayed significantly with time 
(Figure 7.15), so it was necessary to make all measurements of the concentration of ATP 
at exactly the same time after mixing the samples. The period of 30 s to 40 s after mixing 
was therefore chosen for convenience.
It was also possible to construct a standard curve of ATP in amastigote culture 
medium under conditions which mimicked those for treatment of amastigotes with RNI 
(Figure 7.16). This revealed that the foetal calf serum did not contain sufficient ATP to 
disrupt the measurement nor did it contain a highly active ATPase. It also showed that the
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high salt content of the final ATP preparation did not inhibit luciferase sufficiently to 
prevent the assay working.
It was possible to detect the concentrations of ATP present in a culture of 
amastigotes at 2 x 10’ ml ' (Figure 7.17). The light reading was sufficiently high at this 
concentration of amastigotes to allow a lower concentration of amastigotes to be used in 
later experiments. The luminometer reading did not change as quickly in this experiment 
as it did in water, probably because the higher salt concentration of the neutralised 
precipitate partially inhibited the luciferase.
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Table 7.1: Determination of the detectable concentration of ATP.
Amount of ATP in assay Luminometer
/moles reading
0 -0.26
10" 0.89
10" 38.05
10" 8308
ATP was dissolved in water to the concentrations shown, 100 pi was mixed with 100 pi 
firefly luciferase, and the luminescence read at 25°C.
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Figure 7.15: The luminometer reading decays with time.
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Log (moles of 
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The samples from Table 7.1 were followed over time at 25°C.
Figure 7.16: Construction of a standard curve of ATP in SDM + FCS.
.120,r 1001
0 2 4 8 106
[ATP] /iLiM
A standard curve of ATP was constructed in amastigote culture medium. The 
luminescence of a neutralised TCA lysate was measured at 25°C. Results are 
representative of five separate experiments.
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Figure 7.17: Detection of ATP in 10  ^amastigotes.
45 
40 . 
35 _1 30 .
25 .
aoG 20 .
40 80 900 10 20 30 50 60 70
Time after mixing /s
The luminescence of a neutralised TCA lysate of amastigotes (2 x 10^  ml ') was measured 
at 25°C.
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7.4.2 The effect of RNI on the concentration of ATP in amastigotes.
7.4.2.1 Time course
RNI decrease the concentration of ATP in amastigotes very quickly (Figure 7.18). 
The parasites then take up to a few hours to die. This suggests that the amastigotes do not 
have an alternative energy source to which they can turn once their mitochondrion has 
been inhibited.
The first time point shown in Figure 7.18 is 16 s. In this time, the concentration of 
ATP has fallen 50%, illustrating the extremely fast effect of RNI on the concentration of 
ATP.
7.4.2.2 The effect of increasing the concentration of RNI on the concentration of 
ATP.
In Chapter 5 more RNI were shown to kill amastigotes faster. Figure 7.13 suggests 
that inhibition of Rhl23 uptake was complete by a concentration of RNI of approximately 
20 pM HONO, whereas the rate of killing of amastigotes continues to increase even up to 
800 pM HONO (Figure 5.4). This may suggest that the energy production systems of 
amastigotes were still partially functional at these higher concentrations, but that the 
function was not detectable by R hl23 uptake.
This appears to be the case. Increasing the concentration of RNI causes the ATP 
levels to drop faster (Figure 7.19), suggesting that the ATP production system is inhibited 
still further at these higher concentrations.
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In addition, this provides evidence that it is an ATP production system, and not an 
ATP utilisation system that is the primary target of RNI. It also suggests that the ATP 
production system (be it the mitochondrion or glycolysis) does not need to be completely 
inhibited to kill amastigotes, since an incomplete inhibition of ATP production still kills 
the amastigotes, albeit more slowly.
Increasing the concentration of DNP above that which inhibited Rhl23 uptake also 
led to a faster death (Figure 7.20). This suggests that partial inhibition of the 
mitochondrial membrane potential alone gradually leads to a depletion of ATP 
concentration and finally death. Inhibition of the mitochondrion by DNP leads to a fast 
drop in ATP concentrations (Figure 7.21).
The toxicity of RNI can therefore still be accounted for by the inhibition of the 
mitochondrion.
Rhl23 uptake is not a perfect assay for detection of the inhibition of the 
mitochondrial membrane potential. A total inhibition of Rhl23 uptake was observed at 
100 pM DNP and at RNI concentrations of 20 pM FIONO (Figure 7.13 and Figure 7.14). 
Increasing the concentration of both of these toxins above those levels speeds up death, 
indicating that the mitochondrion may be affected still further above the concentrations 
where inhibition could be detected by Rhl23 uptake (Figure 7.20 and Figure 7.21).
191
Figure 7.18: Time course of the effect of RNI on the concentration of ATP in
amastigotes.
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Amastigotes (4 x 10^  ml ’) were treated with RNI (100 HONO) for up to 2 h. the 
concentration of ATP was measured by luminescence, and percentage viability by 
transformation efficiency. Results are expressed as the mean (± SEM n=4 for the viability 
measurements), and are representative of three separate experiments.
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Figure 7.19: The effect of different concentrations of RNI on the concentration of 
ATP.
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Amastigotes (4 x 10^  ml‘‘) were cultured with RNI for up to 4 h. At each time point, the 
concentration of ATP was measured by luminometry of a TCA lysate.
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Figure 7.20: Higher concentrations of DNP kill amastigotes faster.
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Amastigotes (2 x lO'* ml ') were cultured with DNP for up to 4 h in amastigote culture 
medium. At each time point, viability was assayed by transformation efficiency.
I
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Figure 7.21: The effect of different concentrations of DNP on amastigote viability 
and ATP concentrations.
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Amastigotes (4 x 10^ ’ ml ') were treated with RNI or DNP for up to 4 h in amastigote 
culture medium. At each time point viability was assayed by transformation efficiency, 
and the concentration of ATP in a neutralised TCA lysate was measured by luminometry.
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7.5 Discussion
Axenically grown amastigotes are dependent upon energy produced by their 
mitochondrion, since they are susceptible to several mitochondrial toxins - sodium azide 
(Figure 7.1), FCCP (Figure 7.2) and DNP (Figure 7.3).
The toxicity of RNI on amastigotes correlates with inhibition of the mitochondrial 
function (Figure 7.13). The rate at which oxygen was consumed, and the amount of 
uptake of Rhl23 are both measures of the function of the mitochondrion. Both of these 
were inhibited by toxic concentrations of RNI (Figure 7.5 and Figure 7.13)
RNI produced from SNAP inhibit oxygen consumption by amastigotes. This 
suggests that the electron transport chain is inhibited. Many of the RNI can rapidly cycle 
between a protonated neutral membrane-permeable form and an unprotonated ionic form 
(eg NOj and HONO, NO and HNO, ONOO and HONOO), which means that it is 
conceivable that RNI were inhibiting the mitochondrion by uncoupling the membrane. 
However, since oxygen uptake was inhibited by RNI, the inhibition of the electron 
transport chain is also probably a significant factor in the inhibition of ATP synthesis by 
RNI.
Inhibition of oxygen consumption by SNAP (Figure 7.5), and inhibition of R1Ü23 
uptake by acidified sodium nitrite (Figure 7.13) indicates that the mitochondrion can be 
inhibited by RNI produced from a variety of sources. Therefore the toxic mechanism I 
have been studying is not peculiar to the acidified nitrite system.
SNAP uses up oxygen in the medium (Figure 7.5), and it is possible that the
decrease in oxygen tension may contribute to the toxicity of RNI, However, the inhibition
of oxygen uptake by SNAP in our system is not due to SNAP competing for oxygen with
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amastigotes, since below 1 mM SNAP, there is an overall decrease in oxygen consumption 
by the mixture of amastigotes and SNAP.
In vivo, however, the oxygen tension is likely to be much lower since the 
concentration of amastigotes is higher, and there is little vascularisation of the lesion. In 
this instance, the decrease in oxygen concentration caused by RNI may be a significant 
factor in RNI toxicity.
Rhl23 is concentrated in the mitochondrion. This was confirmed by fluorescence 
microscopy in which the basket-like structure of the mitochondrion could clearly be seen. 
Unfortunately, since Rhl 23 cannot be fixed in amastigotes, it was not possible to 
photograph this phenomenon.
Uptake of 13 pM R hl23 for 6 min by amastigotes is in the range where more 
Rhl23 uptake leads to more fluorescence (Figure 7.7). At low concentrations of RNI,
Rhl23 fluorescence does not increase. It is therefore unlikely that RNI are increasing the 
uptake of Rhl23 to such an extent that auto-quenching by Rhl23 causes the decrease in 
fluorescence. So the inhibition of fluorescence by RNI is due to an inhibition of R hl23 
uptake, probably because of an inhibition of the mitochondrial membrane potential.
Inhibition of both Rhl23 uptake and the decrease in the concentration of ATP 
caused by RNI and DNP is very quick (Figure 7.9, Figure 7.18, and Figure 7.21). This 
contrasts with the slow killing by RNI, suggesting that the amastigotes can survive for up 
to a few hours with low levels of ATP.
Amastigotes do not have another energy source from which they can produce 
enough ATP to rescue themselves after their mitochondrion has been inhibited (Figure
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7.18 and Figure 7.19). If they did, then they would be able to maintain their ATP levels 
for longer during treatment with RNI.
Amastigotes are not able to maintain their ATP levels if their mitochondrion has 
been uncoupled with DNP (Figure 7.21). This suggests that they are dependent on their 
mitochondrion for production of enough ATP to survive.
The time course of killing of amastigotes by RNI and DNP is similar - in the range 
of a few hours (Figure 7.21). There is a quick inhibition of the mitochondrion, and a fast 
drop in ATP levels, followed by slower death. This suggests that if the only thing that 
RNI did was to decrease the mitochondrial membrane potential, then the same kinetics of 
killing would be seen as were presented here.
The mechanism of RNI inhibition of mitochondrial function in amastigotes is open 
for speculation. However, in organisms as diverse as E. coli and mammalian cells, RNI 
inhibit the mitochondrion by ligation of nitric oxide to the iron in the iron-sulphur centres 
of the cytochromes (26,221,222). The inhibition of the cytochromes is fast and reversible.
In amastigotes, the toxicity of RNI is also fast and reversible and involves 
inhibition of electron transport flux. It is reversible since washing off the RNI allows the 
amastigotes to transform to promastigotes. The cytochromes are evolutionarily some of 
the best conserved proteins, and the iron-sulphur centres are open to ligation in the same 
way as E, coli and mammalian cells. The toxic mechanism is therefore probably the same 
in amastigotes as it is in these other systems.
In conclusion, the mitochondrion is an important early target of RNI.
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s. General discussion
1 9 8
The results presented in this thesis have provided additional information on 
viability assays for 7,. m. mexicana amastigotes, macrophage toxieity to amastigotes, the 
interaction of RNI with other macrophage defence mechanisms, the response of 
amastigotes to RNI, and the in vitro targets of RNI. However, the main thiast of the 
results is that the most likely mechanism for RNI killing L. m. mexicana amastigotes is the 
inliibition of the mitochondrion, and not direct damage to DNA or to GIPLs. Tire 
relevance of the results to these different processes is now discussed.
8il Viability assays.
The fact that the [^H]-thymidine assay worked for L  m. mexicana amastigotes 
indicates that axenic amastigotes do not synthesise all of the pyrimidine used in DNA 
synthesis. Some eukaryotic protozoa, eg Plasmodium species, live in an enviromnent with 
such a low pyrimidine concentration that they rely totally on synthesis of their own 
pyrimidines, and have lost the thymidine uptake pathways (223). However, Leishmania 
promastigotes have retained the ability to salvage pyrimidines as well as synthesise them 
de novo, and although little is known about amastigote pyrimidine metabolism, they do 
contain at least some of the necessary enzymes for synthesis as well as salvage (244,245).
However, the ability of L. m. mexicana amastigotes to take up thymidine is poor 
compared to mammalian cells and E. coli, since incubation of the parasite for 24 h in 1 
pCi [^H]-thymidine was required to get between 1x10^ and 20 x 10^  cpm incorporated 
(Figure 3.1). This compares with the standard protocol of a 6 h pulse of [^FI]-thymidine 
for immune system cells to get up to 300 x 10^  cpm incorporated (see for example (224)). 
The parasites therefore may rely more heavily on synthesis rather than uptake for their 
drymidine.
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It is possible that variations in the rate of pyrimidine synthesis were responsible for 
the variability in tlie [^H]-thymidine uptake of amastigotes. The [^H]-thymidine uptake 
assay rhay hot therefore directly relate to amastigote proliferation, but may also reflect 
changes in the ratio of de novo pyrimidine synthesis to pyrimidine uptake.
The [^H]-thymidine assay also does not distinguish between chi'omosomal DNA 
and kinetoplast DNA. The kinetoplast is an unusually large amount of mitochondrial 
DMA, composed of minicircles and maxicircles (5). The amount of DNA in the 
kinetoplast is variable (225), and may account for at least some of the DNA synthesis 
detected by the assay.
The [^H]-thymidine assay also does not distinguish between DNA repair and de 
novo DNA synthesis. Since the nick translation reaction revealed that the protocol for 
labelling mammalian cell DNA labelled control parasite DNA extremely efficiently 
(Figure 6.4), it is possible that amastigote DNA contains many nicks or double strand 
breaks in it. This being so, DNA repair may account for much of the [^H]-thymidine taken 
up by amastigotes.
Despite these caveats, toxicity measured by the [^FI]-thymidine assay occur s in the 
same concentration range of RNI as toxicity measured by transformation efficiency 
(Figure 5.2). Hence it is an "effective assay for the detection of RNI toxicity. However, it 
is not necessarily effective for other drugs. For instance, a drug that stimulated de novo 
pyrimidine synthesis may decrease readings fiom the [^H]-thymidirte assay, but increase 
the rate of synthesis of DNA, and hence increase parasite growth.
The transformation assay produced very variable results in terms of numbers of 
promastigotes produced per amastigote between experiments. However, within each 
experiment, the efficiency of transformation between replicates was similar, indicating
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that different treatments could reasonably be compared within each experiment. In the 
experiments presented here, the final promastigote concentration after transformation 
never exceeded 2 x 10  ^m f \  which means that the promastigotes had never reached the 
top end of the assay. Thus the assay was suitable for measuring the viability of the 
parasites within the concentrations at which we were working.
8.2 J774 toxicity to amastigotes.
J774 cells are able to kill amastigotes by an r-arginine dependent mechanism 
(Figure 5.1). This mechanism is not the inhibition of uptake of other cationic amino acids, 
since the effects of l~NMMA were reversible by the addition of excess r-ai'ginine. Nor 
was the mechanism likely to be the production of H2O2, since l-NMMA does not inhibit 
the oxidative burst (81). The toxicity, however, did correlate with the production of RNI.
There are other L-arginine dependent killing mechanisms, though. For instance, 
lysosomes contain short peptides called defensins (189). These molecules are similar in 
stitlcture to bacterial toxin molecules, and are present at extremely high concentrations in 
lysosomes (20-100 mg mf^). They are rich in arginine residues, and the positive charge 
provided by arginine in the sequence is essential to their function. A positive charge on 
arginine residues is maintained by protonation of the side chain, which will be preferred in 
acidic conditions. It is known that the maintenance of acidity is important in the toxicity 
of macrophages to L  major (130). Whether the production of defensins is inliibited by a 
reduction in the L-ai ginine concentration, or whether there is an enzyme in the regulation 
of their synthesis that is affected by l-NMMA is unknown, and deserves further study.
Nevertheless, it seems probable that RNI are involved since macrophages are
I:capable of producing toxic concentrations of RNI. Attack on external targets can be
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inhibited by haemoglobin (66), myoglobin/ascorbate or FeSOVascorbate (153). These 
systems were designed to mop up RNI, and are unlikely to affect defensins. In addition, 
the target of macrophage toxicity is the mitochondrial complexes I and H in tumour cells 
(152), which is more consistent with toxicity due to RNI than due to defensins, which 
should affect the permeability of the outer membrane of the target rather than the 
mitochondrion. Since RNI are therefore a toxic mechanism of macrophages to other cells, 
it is plausible that they are important in macrophage toxicity to Leishmania.
8.3 The interaction of other PV toxins with RNI.
RNI and H2O2 do not affect the toxicity of one another (Figure 4.5). This is 
surprising since they can interact (30), and both H2O2 and O2' synergised with RNI in the 
killing of E. coli (226), while O2' also inhibited RNI toxicity to mammalian cells 
(199,227). It is possible that at very different concentrations of H2O2 or RNI, or in 
different media, they could react to produce enough peroxynitrite to increase the oxidative 
capacity, and therefore the toxicity, of RNI. However, below the toxic concentrations, 
neither affected the toxicity of the other to L. m. rnexicana amastigotes, and at higher 
concentrations, both were toxic on their own.
ROI do not need to be added to the system for them to influence the effect of RNI. 
Since RNI inhibit superoxide dismutase and cytochrome c oxidase (159), RNI can lead to 
an increase in ROI concentration internally in the amastigote. The ROI would be 
produced by the partially inhibited mitochondrial electron transport chain, and would 
therefore be in the ideal position for the resultant peroxynitrite to oxidise the labile iron in 
the [4Fe4S]^^ clusters of the electron transport chain proteins.
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Indeed, this is a more likely scenario than that in which ROI produced by the 
macrophage attacked the amastigote directly since superoxide and peroxynitrite are 
negatively charged, and cannot cross membranes to reach the parasite. Protonation in 
acidic pH, to neutralise their negative charge, will not allow them to cross the membrane 
either, since protonation catalyses their breakdown.
8.4 Amastigote defence mechanisms against RNL
Murine macrophages can produce sufficient RNI to kill amastigotes of L. m. 
mexicana (Figure 3.1). It is interesting that despite the importance that RNI play in 
murine immunity to leishmaniasis, amastigotes have not developed resistance to them 
compared to E. coli (Figure 4.12) or promastigotes of A m. mexicana (Figure 4.6 and 
Figure 4.7). This is not because it is impossible for a cell to become resistant, since 
Mycobacterium intracellulare (46), M  avium (50) and Brucella abortus (202) are not 
killed by RNI produced by macrophages. Culturing amastigotes in low levels of RNI for 
up to three days did not induce resistance (Figme 4.13), indicatingthat the lack of 
resistance is unlikely to be a temporaiy downi egulation of expression of a resistance 
mechanism in BALB/c mice that are not producing much RNl (68). Axenically cultured 
L. m, mexicana amastigotes are simply susceptible to RNI.
It is possible, though, that in vitro cultured amastigotes are not the same as lesion 
amastigotes, and the time it took to assay the toxicity of RNI meant that they had 
sufficiently transfoimed to this in vitro form to lose their resistance to RNI. Lesion 
amastigotes may therefore still be resistant to RNI. In addition, to compare the 
susceptibility of amastigotes and promastigotes to RNI required culturing the two life 
cycle Stages in the same medium for 24 h. This was sufficient time for promastigotes to 
convert to amastigotes at pH 5.5 and 32^0, and amastigotes to convert to promastigotes at
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pH 6.5 and 28°C, it is possible that the experimental design meant that only the most 
susceptible transformation intermediates in both cultures were being compared, and not 
the susceptibility of true promastigotes and amastigotes.
Further reasons for believing that resistance may occur' in vivo and not in vitro 
comes from the mechanisms by which resistance to RNI may be mediated. They could 
include the uptake of iron, concentration of sulphydiyl groups, or the production of a 
neutralising concentration of ROI. In vivo, if an amastigote could actively accumulate 
iron or sulphydryl containing amino acids, it could become resistant to RNI. However, in 
vitro, the iron and sulphydiyl groups are already present in the medium which accounts for 
a much greater proportion of the volume of culture than the amastigotes themselves. Thus 
the accumulation o f sulphydryl groups or iron by the parasite is unlikely to alter the total 
number of these molecules that are available to mop up RNI.
The parasite could, however, alter the groups that bind to the iron or the sulphydryl 
centres. For instance, nitroso adducts of thiol groups in proteins are more stable than 
nitroso adducts of free cysteine (27,161), so synthesis of cysteine-rich proteins may 
protect the parasite against RNI attack. Amastigotes synthesise large amounts of cysteine 
proteases whose function has yet to be determined (24,228), though they are necessary for 
amastigote transformation to promastigotes (229). Because of the high concentration of 
thiol groups in culture medium, their function in mopping up RNI would not be 
detectable. In vivo, though, their accumulation may be very important for protection, as 
Would synthesis of glutathione or tiypanothione (208). The chemical state of iron is also 
important for its activity since myoglobin alone is not very effective at mopping up RNI, 
but myoglobin kept in the ferrous state by ascorbate is effective (153)
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The surface of amastigotes is covered with GIPLs (183,227,230,246), which 
contain long carbohydrate chains. Peroxynitrite reacts with sugars, as does superoxide, so 
these molecules may play a protective role against peroxynitrite.
There is, however, no evidence to suggest that amastigotes are af>le to survive an 
RNI attack from a macrophage. If a macrophage can be activated to produce RNI, then it 
will kill Leishmania (Table 1.3). The defence mechanisms of Leishmania appear to 
concentrate on inhibiting the induction of a Thl response rather than trying to defend the 
parasite against an RNI attack. For instance, L. major infected macrophages preferentially 
provide help for Th2 type cells (38).
A paradoxical quirk of L. major is that it may subvert the host iimnune response by 
allowing itself to be killed by RNI. Promastigotes of this species of parasite enter the 
macrophage “quietly”, preventing the macrophage from releasing IT-12 and thereby 
inducing a T^l response in resistant mice (201). However, amastigotes enter “noisily”, 
allowing a protective T^l response to develop around the outside of a lesion. This 
prevents the parasite from disseminating and incapacitating the host, which may allow the 
host to come into contact with more sandflies. BALB/c mice are unable to produce a T^l 
response even after production of IL-12 (201), thereby explaining the dissemination of L. 
major in this strain of mouse.
However, L. m. mexicana amastigotes and promastigotes both enter murine 
macrophages silently (Locksley,R.M. personal commimication), thereby always 
stimulating a Th2 type response. Compared to L, major, lesions in BALB/c mice from L. 
m. mexicana grow slower and disseminate through this susceptible host more slowly 
(compare 68 to 247). There may therefore be pathways other than the induction of a TiJ 
or Tii2 type immune response that account for the different rates of disease progression.
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Another way that parasites can evade RM  is to infect ceils that do not produce 
RM. Dendritic cells can harbour A. major, and are unable to produce RM  (20,21,231). 
After resistant mice have cleared an infection, it is possible to inhibit RM  production and 
reactivate the disease (232). There is evidence to suggest that parasites inside dendritic 
cells are protected from RM produced by macrophages (21). Since up to 70 % of 
amastigotes are found inside cells that are negative for known macrophage markers (232), 
this may be a significant immune evasion mechanism.
If the in vitro experiments do reflect the in vivo situation, L. m. mexicana may not 
have developed resistance because this strain is a human parasite that is normally self- 
healing in some mouse strains (247). L. m. mexicana forms disseminating lesions in 
BALB/c mice, while five out of six strains of this species formed lesions that began to 
regress in C57B1/6 mice (247). The normal reservoirs for L  m. mexicana are forest 
rodents in rural areas and dogs in urban areas (1,5). Human macrophages do not produce 
RM  as efficiently as mice so it would be interesting to compare the RM production
.capabilities of the dogs and rodents that form the natural reservoirs with laboratoiy 
rodents.
Amastigotes are not more resistant to RM  than J774 cells either (Figure 4.8 and 
Figure 4.9), but it is not known whether murine macrophages can kill amastigotes without 
killing themselves. Since RM can induce apoptosis in some macrophages (192), these 
cells appear to be programmed to kill themselves in response to RM, and may not need to 
kill the amastigotes without committing suicide.
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8.4.1 The kinetics of toxicity.
RNI are cytotoxic to amastigotes. They do not just inhibit parasite proliferation, 
they also kill the parasite at the same time (Figure 3.2). They can take several hours to kill 
amastigotes in vitro (Figure 5.3). Unfortunately it is not yet possible to compare this to 
the time course of killing in a macrophage since it is impossible to detect which cells are 
producing RNI in a given population at a given time. Not only does the expression of 
iNOS not always correlate with production of detectable RNI (233), but it is difficult to 
tell whether a particular macrophage contains amastigotes without killing the macrophage. 
This makes it difficult to identify individual cells that are producing RNl, and the cells in 
which parasites were dying, in order to identify how long parasites were exposed to RNI 
for. It is also not known whether a homogeneous population of cells produces RNI in 
synchrony after stimulation, or whether each cell produces a short burst Of a high 
concentration of RNI, and the gradual accumulation of RNI in the medium is due to 
changes in the number of cells that are releasing RNI.
In addition, the rate at which RNI become detectable in solution depends on the 
balance of reactions in which they react with iron, sulphydiyl groups, and oxygen. NO 
bound to iron may still be toxic to amastigotes, but it will not be detectable in the Griess 
reaction. The same applies to nitiosothiols. This makes it difficult to determine the rate 
at which even a population of macrophages produces RNI.
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8.5 The mechanism of killing.
RNI did not cause apoptosis in parasites since the DNA does not ladder (Figure 
6-13), the chromatin did not condense in the saUae way as an apoptotic mammalian cell 
(Figure 5.7), and the parasites had no ATP (Figure 7.18) or a mitochondrial electron 
potential (Figure 7.9).neceSsaiy to drive the synthesis of new proteins required for 
apoptosis.
Necrosis is a much more likely candidate for the toxic mechanism. Necrosis is 
usually caused by an inliibition of the mitochondrion (188), which prevents the cell from 
maintaining its osmotic balance, and leads to a disruption of intracellular structures, 
especially the mitochondrion. This is what was observed in electron micrographs of 
amastigotes treated with RNl (Figure 5.7).
That a major target of RNI should be the amastigote mitochondrion is not 
surprising. It has long been known that A tropica, L  b. braziliensis, and A donovani are 
dependent on their mitochondrion for energy, since they are susceptible to toxins such as 
cyanide (234). However, there have been indications that the electron transport chain of 
A doHovani promastigotes is different from the mammalian system. For instance oxygen 
consumption is not inhibited by rotenone (a standard inliibitor of complex I of the electron 
transport chain), and -30% of the respiration was insensitive to low concentrations of 
cyanide (248). Oxygen uptake was totally inhibited in these promastigotes by 
thenoyltrifluoroacetone, suggesting that they do have a complex II in their transport chain 
which is required for oxygen consumption.
This work confirmed that amastigotes are susceptible to DNP, sodium azide, and
FCCP, all of which are mitochondrion-specific toxins. In addition, the inhibition of the
mitochondrion by RNI correlates well with the toxicity of RNI (Figure 7,13), as does the
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toxicity of DNP to the mitbchondrioii (Figure 7.14). It is therefore likely that 
mitochondrial energy production is a major target of RNI.
Higher concentrations of RNI kill amastigotes faster, and inhibit ATP production 
faster above the concentration at which one could detect inhibition of the mitochondrion 
with Rhl23 (Figure 7.19 and Figure 7.20). This may be due to RNI inhibiting certain 
components of the glycolytic pathway, for instance glyceraldehyde-3-phosphate 
dehydrogenase (165). However, it may also be that the Rhl23 assay is not sensitive 
enough to detect the low mitochondrial electron potential that is left. This could be 
because the pump that removes Khl23 from the mitochondrion (218) pumps the drug out 
faster than it is accumulated when the membrane potential is low. This theory is 
supported by the fact that increasing the concentration of DNP above that at which it 
maximally inhibits Rhl23 assay also kills amastigotes faster and lowers the concentration 
of ATP faster (Figure 7.21).
That amastigotes are reliant on the membrane potential for maintenance of 
viability assumes that the mechanism of action of DNP is solely the uncoupling of the 
mitochondrial membrane (249). If this is true then inhibition of ATP produc tion by the 
mitochondr ion is sufficient to account for the toxicity of RNI. DNP will reduce the 
NADHNAD ratio by uncoupling the mitochondrion, while RNI should increase this ratio 
by inhibiting complexes I and II. Since the kinetics of the two toxins are reasonably 
similar, this implies that the mechanism of killing may be the same, which fits with the 
inhibition of ATP production rather than changes in the NADHNAD ratio.
It may be that the unusual organisation of the glycolytic enzymes into glycosomes 
(235) in amastigotes may cause them to be susceptible to the H'^-penneability caused by 
DNP. Furthermore, since amastigotes are grown in an acidic medium, DNP could work
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by uncoupling the proton gradient across the parasites’ outer membrane. This would 
probably occur at the same concenti ation of DNP as the uncoupling of the mitochondrial 
membrane. Perhaps the correlation of inhibition of ATP production with toxicity is 
therefore a spurious side effect of this type of toxicity.
8.6 In vivo relevance.
The importance of the mitochondrion in amastigote survival is surprising since a 
lesion has veiy little vascularisation, and the concentration of amastigotes in the lesion is 
extremely high. One would therefore expect the oxygen tension in the lesion to be very 
low, and if the amastigotes are totally dependent on aerobic respiration, it is surprising 
that they can survive under such conditions.
It is possible that the cultured amastigotes are not identical to lesion amastigotes, 
and that the cultured amastigotes are dependent on their mitochondrion, while lesion 
amastigotes are not. In support of this, amastigotes grown in vitro from L. m. mexicana 
are often bigger after one day in culture than lesion amastigotes. Also, the culture system 
used provides most of its energy in carbohydrate form - veiy high concentrations of 
glucose, with fatty acids only in low abundance. Amastigotes are particularly efficient at 
using fatty acids as energy sources, and upregulate their p-oxidation pathway, while 
down-regulating their glycolytic enzymes compared to promastigotes (236). It has been 
suggested that amastigotes in a lesion are better described as in a membrane syncytium 
derived from macrophage membranes than as in macrophages themselves, which would 
provide the amastigotes with a good energy source if they were to use lipids. This means 
that the major energy production systems of amastigotes in a lesion and in vitro may be 
completely different, and inhibition of the mitochondrion may not be lethal to a lesion 
amastigote.
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It is possible, therefore, that amastigotes in vivo are killed by RNI in a veiy 
different way to in vilro. However, there was a 10^-fold difference between the toxic 
concentrations of RNI (Figure 3.11) and the concentrations required to deglycosylate 
GIPLs (Figure 6.2) or damage DNA (Figure 6.14). This large difference would suggest 
that the deamination reactions are still unlikely to be important in vivo.
Mitochondi ial inhibition by RNI is primarily through the inliibition of complexes I 
and n  of the mitochondrial electron transport chain in tumour cells (153) and & coli 
(226). It is highly likely that a similar mechanism is true of amastigotes. Enzymes of the 
electron transport chain are some of the best evolutionarily conserved proteins.
Complexes I and II contain aii active [4Fé4S]^’^  centre, whose iron atom is labile if it is 
oxidised by RNl. The toxicity of RNI is reversible since it is possible to wash off the RNI 
and the amastigotes recover sufficiently to transform to promastigotes efficiently. This is 
consistent with the short term inhibition of mitochondrial function seen in macrophages 
which is presumed to be caused by ligation of the iron in complexes I and II (153).
8.7 RNI inhibition of DNase in serum.
The inhibition of the DNase activity is a very preliminary finding. It is not known 
what DNases are present in Serum so their structure and possible inhibition mechanism is 
the subject of pure speculation. Though the concentration of RNI necessary for complete 
inhibition of the activity in a four hour assay was extremely high (Figure 6 .15), in vivo 
production of RNI may involve different ratios of the different RNI, and may be able to 
target the particular DNase. Biological effects may also be seen if the DNase activity is 
only partially inhibited.
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This inhibition has several important implications. Firstly, in the autoimmune 
disease, systemic lupus erythematosus, anti-dsDNA antibodies may be pathogenic (237). 
Since RM  are present in an initial inflammatory lesion, they may prolong the half life of 
DNA that is released from necrotic cells, thereby allowing the formation of anti-DNA 
antibodies, thereby contributing to the disease.
In addition, DNA released from necrotic cells will still be bound to histones. DNA 
from apoptotic cells forms ladders on ethidium bromide gels because the linker DNA 
between the histones is particularly susceptible to DNase digestion (188). The serum 
DNase activity is strong enough to digest all the DNA that is released from necrotic cells, 
whether it is bound to histones or not. So normally, all the DNA from necrotic cells is 
digested quickly. Since RM  can inhibit this DNase activity, in certain instances it may 
inhibit the DNase activity only sufficiently for the DNase to create a ladder rather than 
digesting all the DNA. The kinetics of this inhibition are totally open to speculation, but 
in some circumstances, RM  may be expected to create DNA ladders from a necrotic 
rather than an apoptotic population of cells.
In an inflammatory lesion, the production of RM may prolong the half life of 
released DNA for long enough to allow neighbouring cells to take up the DNA and 
express peptides coded by it in conjunction with MHC=I. The success of DNA vaccines in 
the induction of protective immunity Si%mmX Leishmania (238,239), as well as many 
viruses (240,241), suggests that this may provide a mechanism for long term production of 
immunity.
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8.8 Chemical targets of RNI in Leishmania,
In correlation with the rate constants for the reaction of RNI with amine groups, 
sulphydryl groups and iron, the two processes examined that involve deamination 
reactions, ie damage to DNA and GIPLs, are not likely to be significant in the toxicity of 
RNI. The concentrations of RNI required to Cause damage were so much higher than 
those required to kill amastigotes that they are likely to be insignificant reactions.
Slight alterations in the type of RNI to which the DNA is exposed are also unlikely 
to make these reactions important. Altering the pH only affected the rate of deamination 
of guanine by less than two^fold (171), while there needs to be almost a lOOO^ f^old 
increase in the rate before DNA or GIPLs are affected significantly. Amino acids are also 
unable to compete for nitrosylation of sulphydryl groups unless they contain a sulphydryl 
group themselves (31). It is therefore unlikely that these deamination reactions are 
important in vivo.
The nick translation reaction did not detect direct damage to DNA by RNI (Figure 
6.14). The sort of damage that occurred at extremely high concentrations of RNI was 
much more consistent with a deamination reaction, which led to less labelling of the 
DNA, and with a cross-linking reaction that prevented the DNA from leaving the wells of 
the ethidium bromide gel. In vivo, however, deamination of the DNA causes the strands 
to stop base-pairing properly (171), and the resulting deaminated base is unstable in the 
double helix (175). In acidic solution, improperly base«paired DNA can lose its purines, 
becoming apurinated (175). Apurinated DNA can be attacked by basic species such as 
histones, or basic amino acids to break the DNA strand (242). This would allow extra 
labelling of DNA by nick translation. The rate of deamination is veiy variable, and can be 
affected by base sequence, the structure of the histones, the pH, the salt and the amino
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acid concentration (171). It is therefore possible that such a mechanism could occur in 
mammalian cells and not in parasite cells. Because of all these factors, it would be 
completely impossible to mimic such a situation in vitro to make proper comparisons of 
the rate of killing to the rate of damage.
8.9 RNI production by acidified nitrite.
The system for RM  production by acidification of nitrite in amastigote culture 
medium has several major advantages over production of RM by all the other available 
mechanisms. For instance, it produces a constant amount of RM  that is still toxic 24 h 
later (Figure 3.13), while NO gas bubbled through medium has a very short half life (33), 
and S-nitrosothiols in solution also have a very short half life and their breakdown is 
catalysed unpredictably in biological solutions by transition metal ions (28). 
Unfortunately, acidified nitrite is not suitable for assaying the effects of RNI in medium 
designed for mammalian cells, since the amount of sodium nitrite required to get the 
concentrations of RM  used here at pH 7.4 is in the molar range. Not only is that at the 
bounds of solubility for sodium nitrite^ but it is also likely to be toxic due to osmolarity 
considerations.
Though acidified nitrite is better than most methods for producing RM, it is
important to note that the toxic mechanism in the system described here may not be the
same as the in vivo toxic mechanism. RM  produced in this system is produced by the
reverse reaction to the in vivo situation. In vitro, the sodium nitrite anion is protonated to
become nitrous acid, which reacts with sulphydryl groups, iron centres, molecular oxygen
and amine groups to produce all the RM. In vivo, RM  are produced by NOS converting
L-arginine to L-citrulline and either NO or NO". The rate o f production of the different
RM  is likely to be different in the two situations, and is also likely to be greatly affected
214
by the difference in the protein, peptide, oxygen and salt concentrations, as well as the 
redox potential and the concentration of parasites. These other factors make it impossible 
to mimic the in vivo situation in vitro. However, the acidification of nitrite is the most 
effectively controllable method available for in vitro production of RNI.
There is evidence that the important RM species are those that are favoured by 
acidic conditions since acidification of the vacuole correlates with toxicity (130). In 
addition, it is possible to inhibit RM  toxicity by the addition of small thiol containing 
molecules (31), suggesting that S-nitroso-cysteine or S=nitroso-glutatliione are unlikely to 
be important toxic molecules themselves, though they may be involved in the transport of 
RM  across membranes. Peroxynitrite is possibly important, especially as the toxicity of 
acidified nitrite correlates with inhibition of the mitochondrion, which may be more 
strongly inhibited by peroxynitrite than nitric oxide (155,156). If this had been the case, 
though, we would have expected to see a significant change in the toxicity when RM  were 
mixed with H^Oj, since peroxynitrite would have been the most likely candidate to have 
been affected by this reaction.
However, it need not be peroxynitrite produced outside the amastigote that is 
important, since RM inhibition of the elecü on transport chain may lead to greater 
production of superoxide, which may then react with RM  to form peroxynitrite. This is a 
more likely scenario, since the negatively charged peroxynitrite would probably find it 
difficult to cross the dense sugar matrix surrounding amastigotes and the membrane 
barrier, and not reach the mitochondrion.
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8.10 Future experiments
The most important question to be answered is “Is the inhibition of the 
mitochondrion an important factor in RNI toxicity in vivoT\ A  new derivative of Rhl23 
called Mitofluor Green FM, that has recently come on the market may help to answer the 
question (217). This derivative is a fluorescent dye that is also driven into the 
mitochondrion by the membrane potential, but unlike Rhl23 it is fixable in situ with 
agents such as formaldehyde. Injection of the dye into a lesion in CBA mice may label 
parasites with functional mitochondria. It may be possible to find examples of parasites 
that had inhibited mitochondria, possibly in macrophages that surrounded the lesion.
It may also be possible to detect formation of iron-nitrosyl complexes by electron 
spin resonance(243) from macrophages that surrounded the lesion. It would, however, not 
be possible to assign the resonant frequencies to mitochondrial proteins from amastigotes, 
because it would be unlikely that the frequencies would be sufficiently different from the 
mammalian frequencies.
Failing that, it may be possible to determine whether a macrophage can clear itself 
of an infection without killing itself, using a quantitative analysis of the number of 
infected macrophages in a culture over a time course. However, even if a population of 
macrophages was infected, and after stimulation there were live, uninfected macrophages, 
it would be possible to argue that since in vitro infection experiments never produce 100 
% of the macrophages being infected, the uninfected macrophages may never have been 
infected and never produced RNI, and so were able to divide more efficiently than the 
infected macrophages. Since certain Leishmania products are able to activate RNI 
production in synergy with IFNy, this would be a reasonable scenario.
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